Drug-induced adrenocortical insufficiency

DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E27.3# 1 out of 7 registries used, show all original rules.	761
4. Check minimum number of events None	761
5. Include endpoints None	761
6. Filter based on genotype QC (FinnGen only)	687

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E273
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Drug-induced adrenocortical insufficiency based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2471	1595	868
Only index persons	2275	1493	782
Unadjusted period prevalence (%)
Whole population	0.04	0.05	0.02
Only index persons	0.05	0.05	0.03
Median age at first event (years)
Whole population	57.01	57.43	56.23
Only index persons	58.04	57.88	58.36

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	687	470	217
Unadjusted period prevalence (%)	0.15	0.17	0.10
Median age at first event (years)	59.94	57.39	65.46

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
711: Matched controls
7110

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB09

ATC

hydrocortisone; systemic

831.8

307.7

623

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

+∞

307.7

711

J45.9

ICD-10 Finland

Asthma, unspecified

8.4

183.7

398

932

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

8.3

179.3

387

899

R03BB04

ATC

tiotropium bromide; inhalant

9.9

175.6

256

384

J46

ICD-10 Finland

Status asthmaticus

21.5

166.2

131

R03AK08

ATC

formoterol and beclometasone; inhalant

13.3

164.8

175

170

J45.0

ICD-10 Finland

Predominantly allergic asthma

9.1

156.0

238

373

H02AB06

ATC

prednisolone; systemic

12.9

154.4

627

2610

R03DC03

ATC

montelukast; oral

6.6

136.5

327

808

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

235.3

133.8

134

J45.1

ICD-10 Finland

Nonallergic asthma

9.0

133.8

195

286

L04AX01

ATC

azathioprine; systemic

12.2

125.9

137

136

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

8.3

115.5

178

276

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.7

114.3

469

1794

R03AK06

ATC

salmeterol and fluticasone; inhalant

6.1

113.4

269

645

J45.8

ICD-10 Finland

Mixed asthma

13.7

110.9

110

R03DA04

ATC

theophylline; systemic, rectal

10.7

106.4

126

140

R96

ICPC

Asthma

6.5

101.6

206

422

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

11.8

100.5

110

109

R03AC12

ATC

salmeterol; inhalant

10.0

100.0

125

149

C03CA01

ATC

furosemide; systemic

5.0

99.3

360

1214

XG474

NOMESCO Finland

Exhalation nntrogen oxide

11.3

92.1

103

105

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.3

90.2

533

2559

J45

ICD-10 Finland

Asthma

5.7

86.8

199

452

R03BA08

ATC

ciclesonide; inhalant

6.0

86.6

183

386

R03BA05

ATC

fluticasone; inhalant

4.7

84.5

283

879

H02AB04

ATC

methylprednisolone; systemic

5.0

83.3

234

631

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

8.1

81.7

120

173

R03BA01

ATC

beclometasone; inhalant

5.1

81.5

219

568

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.4

80.8

326

1158

L04AX03

ATC

methotrexate; systemic

5.6

79.6

185

423

J01MA14

ATC

moxifloxacin; systemic

5.9

79.4

171

365

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

9.8

78.4

113

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

835.0

77.9

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

7.6

77.3

120

184

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.5

77.2

143

264

R03AC13

ATC

formoterol; inhalant

7.5

74.3

117

182

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.9

74.0

208

556

WZC30

NOMESCO Finland

Teaching

4.5

73.6

247

758

Z01.8

ICD-10 Finland

Other specified special examinations

4.1

71.6

299

1072

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.9

71.3

359

1463

H02AA02

ATC

fludrocortisone; oral

36.0

69.5

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

7.5

68.3

107

165

M05BA04

ATC

alendronic acid; oral

5.7

67.1

144

304

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.8

67.0

185

484

R06.0

ICD-10 Finland

Dyspnoea

3.8

66.8

335

1349

R03DC01

ATC

zafirlukast; oral

14.0

66.5

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

28.2

65.9

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.0

63.5

164

405

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

19.1

62.5

UJF32

NOMESCO Finland

Coloscopy

3.7

61.6

310

1238

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

27.8

61.2

R50.9

ICD-10 Finland

Fever, unspecified

4.1

59.8

219

704

N03AX12

ATC

[U] gabapentin; oral

3.9

59.2

230

770

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

17.7

57.8

N02AA05

ATC

oxycodone; systemic

3.9

57.3

228

774

J01MA12

ATC

levofloxacin; systemic

3.8

56.4

226

770

A07AA02

ATC

nystatin; oral

5.8

55.4

111

218

H02AB07

ATC

prednisone; oral

4.1

55.1

188

571

R03AC02

ATC

salbutamol; inhalant

3.9

55.1

546

3255

E23.03

ICD-10 Finland

Lack of ACTH

154.6

54.7

TPH04

NOMESCO Finland

Cathetrisation of vein

3.5

54.3

268

1043

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

4.9

53.8

135

323

105

Kela drug reimbursment

Adrenal cortical hypofunction

198.3

53.7

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.8

53.7

212

712

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.6

53.0

237

864

SPAT1148

SPAT

Treatment of chronic ulcer or burn

4.1

52.6

176

526

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.8

51.8

108

N06AX21

ATC

duloxetine; oral

4.0

51.6

183

569

A01AB09

ATC

miconazole; local oral

4.7

51.1

134

332

JN3AD

NOMESCO Finland

Abdominal CT examination

3.9

51.0

184

579

R53

ICD-10 Finland

Malaise and fatigue

3.3

50.9

294

1251

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.3

50.8

277

1138

L04AA06

ATC

mycophenolic acid; systemic

11.4

50.3

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.4

50.2

246

946

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.3

49.7

151

419

R06AE07

ATC

cetirizine; oral

3.2

48.6

441

2417

N02AX02

ATC

tramadol; systemic, rectal

3.1

48.6

427

2298

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.9

48.4

119

279

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

7.7

48.3

101

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

8.1

47.9

R03BA02

ATC

budesonide; inhalant

3.4

47.8

230

871

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.6

47.6

200

694

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

8.7

47.2

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

8.1

47.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.8

46.3

117

280

M05BX04

ATC

denosumab; parenteral

5.4

45.9

100

211

L01BA01

ATC

methotrexate; systemic

7.4

45.8

104

TQW80

NOMESCO Finland

Local dermatologic skincare

8.8

45.5

R03AK07

ATC

formoterol and budesonide; inhalant

3.2

45.5

250

1022

N03AX16

ATC

[U] pregabalin

3.2

45.4

266

1128

R03AK11

ATC

formoterol and fluticasone; inhalant

8.7

45.0

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

5.1

45.0

105

235

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.6

45.0

129

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

5.5

44.7

192

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

15.1

44.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.2

44.3

134

369

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

3.0

44.2

306

1423

R02

ICPC

Shortness of breath/dyspnoea

3.6

43.9

176

590

WZC00

NOMESCO Finland

Treatment plan or consultation

2.9

43.4

378

1985

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.6

42.9

175

592

J47

ICD-10 Finland

Bronchiectasis

10.1

42.9

ZX120

NOMESCO Finland

Intravenous

4.1

42.7

136

388

E0000UV, ,

ATC

2.9

42.7

413

2288

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.8

42.5

158

R03BB01

ATC

ipratropium bromide; inhalant

6.8

42.2

110

A02BC05

ATC

esomeprazole; systemic

2.9

42.2

400

2188

R01AD01

ATC

beclometasone; nasal

3.4

41.9

197

728

R11

ICD-10 Finland

Nausea and vomiting

4.1

41.2

132

378

J01MA02

ATC

ciprofloxacin; systemic

2.8

40.8

362

1902

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.1

40.8

127

356

SPAT1260

SPAT

Consultation of another employee

3.3

40.7

195

728

SPAT1254

SPAT

Administration of medicine

3.6

40.6

166

561

A02BC01

ATC

omeprazole; systemic

2.9

40.5

282

1303

SPAT1255

SPAT

Intravenous administration of medicine

5.1

40.0

203

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.4

39.6

109

278

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.4

39.4

109

279

L04AA13

ATC

[U] leflunomide

8.6

39.3

C01CA24

ATC

epinephrine; parenteral

4.4

39.0

110

286

J01FF01

ATC

clindamycin; systemic

2.9

38.9

281

1318

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

6.1

38.7

127

S97

ICPC

Chronic ulcer skin

4.7

38.5

235

S18

ICPC

Laceration/cut

2.8

38.4

443

2637

SPAT1262

SPAT

Handing over of treatment supplies

3.2

38.4

188

709

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

7.6

38.2

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.1

38.2

119

333

SPAT1153

SPAT

Removal of sutures

2.8

38.2

308

1528

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

6.7

37.9

102

R60.0

ICD-10 Finland

Localized oedema

3.5

37.9

158

539

SPAT1263

SPAT

Sampling

2.7

37.6

381

2117

L04AD01

ATC

ciclosporin; systemic

9.9

37.5

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

6.7

37.4

100

A07EA06

ATC

budesonide; oral, local oral

5.7

37.3

139

AA1AD

NOMESCO Finland

CT of head and brain

2.8

36.6

283

1368

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.7

36.5

372

2063

L04AB01

ATC

etanercept; parenteral

10.8

36.3

318

Kela drug reimbursment

Teriparatide

50.7

36.1

C07AB07

ATC

bisoprolol; oral

2.7

35.7

421

2500

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

4.8

35.7

201

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.7

35.4

131

412

R03AC03

ATC

terbutaline; inhalant

3.3

35.0

163

593

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.6

34.9

131

416

A02BC02

ATC

pantoprazole; systemic

3.3

34.8

579

4076

N02BF01

ATC

gabapentin; oral

3.5

34.8

144

487

L28

ICPC

Limited function/disability (L)

3.0

34.8

202

835

H03AA01

ATC

levothyroxine sodium; systemic

2.8

34.7

250

1159

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.3

34.6

153

539

A41.9

ICD-10 Finland

Sepsis, unspecified

6.5

34.6

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

34.6

354

1953

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.1

34.5

175

670

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.6

34.0

129

412

A06AD11

ATC

lactulose; oral

3.3

33.9

154

551

H05AA02

ATC

teriparatide; parenteral

52.8

33.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.5

33.6

137

458

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.9

33.5

206

877

R01AD08

ATC

fluticasone; nasal

2.6

33.4

289

1464

49300

ICD-8 Finland

Asthma, bronchiale

8.0

33.0

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

6.4

33.0

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.6

32.9

395

2333

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

8.6

32.8

A03FA01

ATC

metoclopramide; systemic, rectal

2.7

32.6

242

1133

A46

ICD-10 Finland

Erysipelas

3.2

32.5

157

582

SPAT1301

SPAT

No procedures

2.6

32.5

292

1503

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.5

32.4

399

2380

A07EC01

ATC

sulfasalazine; oral, rectal

3.9

32.3

108

316

SPAT1149

SPAT

Suture or treatment of traumatic wound

3.4

32.3

137

469

UDH02

NOMESCO Finland

Rhinopharyngoscopy

4.0

32.3

101

282

R06AE09

ATC

levocetirizine; oral

3.1

32.3

165

632

C03DA01

ATC

spironolactone; oral

3.4

32.3

136

464

NH3EA

NOMESCO Finland

Feet X-ray examination with load

7.7

32.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.6

32.1

119

374

ZYC01

NOMESCO Finland

Remote contact by phone

4.1

32.0

265

P01BA02

ATC

hydroxychloroquine; oral

3.7

31.9

114

349

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

5.0

31.8

160

TDM10

NOMESCO Finland

Puncture of maxillary antrum

5.2

31.6

141

M13.9

ICD-10 Finland

Arthritis, unspecified

4.0

31.5

100

282

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.6

31.5

118

373

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.8

31.4

109

327

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.4

31.2

127

SPAT1310

SPAT

Counselling related to known health issue

2.5

30.9

296

1561

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

7.8

30.8

J01FA06

ATC

roxithromycin; oral

2.5

30.8

363

2106

A07EC02

ATC

mesalazine; oral, rectal

4.5

30.7

199

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

8.6

30.6

L95

ICPC

Osteoporosis

5.1

30.6

141

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

5.8

30.5

107

M81.4

ICD-10 Finland

Drug-induced osteoporosis

34.3

30.3

J02AC01

ATC

fluconazole; systemic

2.5

30.3

377

2237

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

30.2

266

1346

N06AA09

ATC

amitriptyline; systemic

3.4

30.1

122

405

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

5.0

30.1

147

WZC00, ,

SPAT

3.0

30.0

159

620

L04AB04

ATC

adalimumab; parenteral

6.7

29.9

SPAT1325

SPAT

Vaccination

2.5

29.8

300

1613

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

4.7

29.5

170

L04AA01

ATC

[U] ciclosporin

11.5

29.5

N06AX16

ATC

venlafaxine; oral

2.9

29.5

172

706

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

5.9

29.4

100

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.5

29.3

463

3040

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.1

29.2

141

520

SPAT1229

SPAT

Assessment of need for aid

4.0

29.2

248

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.8

28.9

156

A07AA09

ATC

vancomycin; oral

10.1

28.7

R5140

NOMESCO Finland

Monitoring the use of the aid

3.2

28.7

132

473

XQ800

NOMESCO Finland

Prick test

3.7

28.6

101

306

M81.9

ICD-10 Finland

Osteoporosis, unspecified

4.6

28.6

166

N02AJ06

ATC

codeine and paracetamol; systemic

2.4

28.4

391

2403

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.1

28.4

135

493

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

4.4

28.3

189

XG410

NOMESCO Finland

Flow-volume spirometry

5.2

28.2

123

A02BA02

ATC

ranitidine; systemic

2.7

28.0

195

875

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.7

27.9

301

J01FA09

ATC

clarithromycin; systemic

2.4

27.9

300

1652

TGC00

NOMESCO Finland

Bronchial lavation

6.2

27.8

R52.2

ICD-10 Finland

Other chronic pain

4.7

27.5

154

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.1

27.5

J32.4

ICD-10 Finland

Chronic pansinusitis

8.7

27.2

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

4.9

26.7

133

ZX112

NOMESCO Finland

Subcutaneous

6.4

26.6

A02BC03

ATC

lansoprazole; oral

2.4

26.5

268

1429

N05BA04

ATC

oxazepam; oral

2.4

26.4

253

1317

E27.2

ICD-10 Finland

Addisonian crisis

+∞

26.2

R51.80

ICD-10 Finland

Headache

2.7

26.2

177

780

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.3

26.2

365

2230

R06AX26

ATC

fexofenadine; oral

3.6

26.1

298

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.4

26.0

289

1603

N02BF02

ATC

pregabalin; oral

3.7

25.9

274

SPAT1249

SPAT

Treatment-related counselling outside office

2.3

25.9

335

1980

M79.7

ICD-10 Finland

Fibromyalgia

4.6

25.8

149

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.3

25.8

109

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.8

25.6

152

626

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

6.2

25.5

G47.3

ICD-10 Finland

Sleep apnoea

2.5

25.5

222

1103

SPAT1312

SPAT

General health counselling

2.3

25.3

278

1530

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

7.2

25.2

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.0

25.2

123

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.4

25.2

250

1317

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.4

25.1

227

1146

XX3DW

NOMESCO Finland

Time consuming IT work

3.0

25.1

126

473

E000001, ,

ATC

2.6

25.0

192

899

M48.0

ICD-10 Finland

Spinal stenosis

3.0

25.0

131

504

N03AE01

ATC

clonazepam; systemic

4.1

24.9

198

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

6.5

24.7

R4180

NOMESCO Finland

Podiatric therapy

9.0

24.7

GD1AD

NOMESCO Finland

Thorax CT examination

3.8

24.6

238

E000002, ,

ATC

3.1

24.6

119

437

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

24.6

263

1428

R60.9

ICD-10 Finland

Oedema, unspecified

3.9

24.4

220

J01FA15

ATC

telithromycin; oral

3.1

24.3

116

423

R03AK03

ATC

[U] fenoterol and ipratropium bromide

4.5

24.2

148

B01AB05

ATC

enoxaparin; parenteral

2.3

24.1

281

1579

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.3

24.0

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.5

24.0

283

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.1

24.0

185

ZX114

NOMESCO Finland

Intramuscular

7.7

23.9

WX723

NOMESCO Finland

CPAP therapy

4.4

23.9

154

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

23.8

255

1381

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.2

23.7

104

360

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.9

23.7

132

524

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.7

23.6

M54.4

ICD-10 Finland

Lumbago with sciatica

2.5

23.4

193

930

D07AC01

ATC

betamethasone; topical

2.2

23.4

317

1889

M01CB01

ATC

sodium aurothiomalate; parenteral

10.0

23.3

JN4AD

NOMESCO Finland

Body CT examination

3.0

23.3

121

462

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

5.1

23.3

107

N06AX11

ATC

mirtazapine; oral

2.2

23.1

310

1839

NF1AA

NOMESCO Finland

Hip X-ray examination

3.3

23.0

328

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.4

22.8

292

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

22.7

182

865

M05BA07

ATC

risedronic acid; oral

5.7

22.7

J30.3

ICD-10 Finland

Other allergic rhinitis

4.4

22.6

143

WX892

NOMESCO Finland

Monitored bed care

3.4

22.6

283

ZXA10

NOMESCO Finland

Bilateral

2.5

22.5

177

833

N30.0

ICD-10 Finland

Acute cystitis

2.5

22.3

170

788

N05AH04

ATC

quetiapine; oral

2.5

22.0

176

834

M54.5

ICD-10 Finland

Low back pain

2.2

22.0

323

1975

E87.6

ICD-10 Finland

Hypokalaemia

4.5

22.0

129

J01DB01

ATC

cefalexin; oral

3.2

21.8

638

5184

R03BC03

ATC

nedocromil; inhalant

3.4

21.7

274

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.4

21.7

204

1039

M79.6

ICD-10 Finland

Pain in limb

2.1

21.6

383

2513

Z71.8

ICD-10 Finland

Other specified counselling

2.2

21.6

308

1859

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

44.8

21.5

A07EA02

ATC

hydrocortisone; rectal

6.2

21.4

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.2

21.4

268

1535

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.6

21.4

220

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.6

21.3

231

N03AX09

ATC

lamotrigine; oral

3.8

21.2

192

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

17.2

21.1

N02AC04

ATC

dextropropoxyphene; oral

5.0

21.1

100

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.4

21.1

129

L88

ICPC

Rheumatoid/seropositive arthritis

4.2

21.0

147

B80

ICPC

Iron deficiency anaemia

5.7

20.9

K51.8

ICD-10 Finland

Other ulcerative colitis

7.3

20.9

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

5.1

20.9

E000003, ,

ATC

4.1

20.9

152

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.2

20.9

308

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

4.8

20.8

105

SPAT1211

SPAT

Application of soft bandage

3.1

20.8

325

E27.9

ICD-10 Finland

Disorder of adrenal gland, unspecified

216.1

20.7

UJF92

NOMESCO Finland

Capsular endoscopy

6.2

20.6

R01AD12

ATC

fluticasone furoate; nasal

2.1

20.5

284

1686

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.4

20.5

252

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.5

20.5

150

680

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.8

20.4

116

463

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.2

20.4

237

1312

OAB50, ,

SPAT

3.2

20.4

312

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.8

20.4

103

R01AD05

ATC

budesonide; nasal

3.2

20.3

307

A04AA01

ATC

ondansetron; systemic, rectal

3.0

20.3

352

J31.0

ICD-10 Finland

Chronic rhinitis

2.9

20.2

103

388

R01BA52

ATC

pseudoephedrine, combinations; oral

2.1

20.2

273

1604

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

20.2

114

454

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.1

20.2

C10AC01

ATC

colestyramine; oral

5.1

20.2

K51.5

ICD-10 Finland

Left sided colitis

5.1

20.2

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.7

20.2

108

K50.1

ICD-10 Finland

Crohn disease of large intestine

8.2

20.1

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.9

20.1

104

395

A10AB05

ATC

insulin aspart; parenteral

3.2

20.1

282

K50.9

ICD-10 Finland

Crohn disease, unspecified

7.2

20.1

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

4.1

20.0

152

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.6

20.0

215

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.9

19.9

J01AA02

ATC

doxycycline; systemic

2.6

19.8

597

4756

S01GX01

ATC

cromoglicic acid; ophthalmic

2.3

19.7

198

1031

ZXD05

NOMESCO Finland

Urgent procedure

2.1

19.7

256

1478

J01FA10

ATC

azithromycin; systemic

2.1

19.7

474

3441

C07AB02

ATC

metoprolol; systemic

2.4

19.6

162

776

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.9

19.5

169

R01AD09

ATC

mometasone; nasal

2.1

19.5

389

2631

D64.9

ICD-10 Finland

Anaemia, unspecified

2.9

19.5

372

A01

ICPC

Pain general/multiple sites

2.8

19.5

113

456

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.3

19.4

183

927

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

19.4

127

545

WW200

NOMESCO Finland

Immunization

5.4

19.3

RD211, ,

NOMESCO Finland

4.0

19.3

147

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

5.1

19.2

N05BA01

ATC

diazepam; systemic, rectal

2.6

19.1

130

568

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.0

19.1

324

R4190

NOMESCO Finland

Nutritional therapy

3.8

19.1

167

TAB00

NOMESCO Finland

Lumbar puncture

3.7

19.0

182

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.3

18.9

L01BB02

ATC

mercaptopurine; oral

8.3

18.9

WZA10

NOMESCO Finland

Extensive medical or dental certificate

7.0

18.8

N05CF01

ATC

zopiclone; oral

2.1

18.8

271

1622

127

Kela drug reimbursment

Transplant complication

7.5

18.8

I50.9

ICD-10 Finland

Heart failure, unspecified

2.7

18.8

111

452

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.3

18.7

245

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

4.4

18.6

115

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.1

18.6

243

1401

K50.8

ICD-10 Finland

Other Crohn disease

6.6

18.5

D07AB08

ATC

desonide; topical

2.7

18.4

112

463

WX725

NOMESCO Finland

Noninvasive ventilation

3.4

18.3

217

P01AB01

ATC

metronidazole; oral, rectal

2.0

18.2

342

2246

R06AX13

ATC

loratadine; oral

2.4

18.2

148

702

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

18.1

250

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

3.5

18.1

203

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.3

17.9

230

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

18.7

17.9

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

5.2

17.8

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.7

17.7

105

427

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.9

17.7

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

3.7

17.7

166

Z00.0

ICD-10 Finland

General medical examination

2.2

17.7

175

901

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.5

17.5

125

557

EBA10

NOMESCO Finland

Operative extraction of tooth

2.6

17.5

116

499

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.0

17.3

290

A28

ICPC

Limited function/disability NOS

2.3

17.2

148

717

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.2

17.2

187

999

R52.9

ICD-10 Finland

Pain, unspecified

2.6

17.1

111

472

A04

ICPC

Weakness/tiredness general

2.4

17.1

143

684

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

5.7

17.1

D07AA02

ATC

hydrocortisone; topical

2.4

17.1

138

651

D50.8

ICD-10 Finland

Other iron deficiency anaemias

7.4

17.0

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.4

16.9

136

640

M35.7

ICD-10 Finland

Hypermobility syndrome

6.4

16.8

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.6

16.8

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

16.8

252

1518

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.2

16.6

112

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

16.6

248

1490

3028

Kela drug reimbursment

Mepolizumab

173.9

16.6

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.6

16.6

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.7

16.5

101

417

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.9

16.5

414

2965

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.9

16.5

131

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.9

16.4

299

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.3

16.3

206

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

16.3

100

414

C08CA01

ATC

amlodipine; oral

2.0

16.2

291

1860

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.4

16.2

B01AB10

ATC

tinzaparin; parenteral

2.5

16.1

110

479

B01AA03

ATC

warfarin; systemic

2.4

16.1

132

625

R01AD11

ATC

triamcinolone; nasal

2.7

16.1

385

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

48.7

16.1

N03AX14

ATC

levetiracetam; systemic

4.8

16.0

SAA04

NOMESCO Finland

Special examination of mouth

3.3

16.0

203

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

6.3

16.0

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

3.3

15.9

204

A03FA02

ATC

cisapride; oral, rectal

3.0

15.9

264

K07.60

ICD-10 Finland

Snapping jaw

3.2

15.9

215

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

15.8

376

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

4.6

15.8

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

4.6

15.8

WVA20, ,

SPAT

3.8

15.8

135

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

7.4

15.8

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.0

15.7

117

L17

ICPC

Foot/toe symptom/complaint

2.0

15.7

264

1647

A01AB04

ATC

amphotericin B; local oral

3.6

15.7

160

L03

ICPC

Low back symptom/complaint

2.0

15.6

251

1540

J01EA01

ATC

trimethoprim; systemic

2.0

15.6

218

1273

G43.9

ICD-10 Finland

Migraine, unspecified

3.1

15.6

244

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

5.5

15.5

297, ,

Kela drug reimbursment

163.5

15.5

T78.4

ICD-10 Finland

Allergy, unspecified

3.6

15.5

156

XQ848

NOMESCO Finland

Dermatological photography

4.4

15.5

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

39.0

15.4

B03BA03

ATC

hydroxocobalamin; parenteral

3.5

15.4

167

M25.5

ICD-10 Finland

Pain in joint

1.9

15.3

295

1921

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.8

15.3

316

A03

ICPC

Fever

2.2

15.3

155

802

M01AH01

ATC

celecoxib; oral

2.2

15.3

154

795

R01AD58

ATC

fluticasone, combinations; nasal

2.0

15.2

221

1307

QDB10, ,

SPAT

4.4

15.2

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

3.8

15.2

129

E66.8

ICD-10 Finland

Other obesity

3.1

15.2

226

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

5.8

15.2

UDC00

NOMESCO Finland

Ear microscopy

2.9

15.2

294

D07AD01

ATC

clobetasol; topical

2.2

15.1

155

805

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

15.1

168

901

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.6

15.1

D02AE01

ATC

carbamide; topical

3.1

15.0

222

SPAT1216

SPAT

Assessment of functional ability

2.3

15.0

127

609

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

15.0

140

700

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

15.0

139

693

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.0

15.0

239

H26.3

ICD-10 Finland

Drug-induced cataract

15.5

15.0

XQ802

NOMESCO Finland

Epicutan test

3.6

14.9

150

A12AA04

ATC

calcium carbonate; oral

7.0

14.9

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

14.9

122

576

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.2

14.9

ZXE20

NOMESCO Finland

More than three and less than five hours

2.4

14.9

120

563

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.0

14.9

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.8

14.8

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

18.9

14.8

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

14.7

157

827

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.5

14.6

152

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.9

14.6

265

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.8

14.6

Z3231

NOMESCO Finland

Registered nurse

2.0

14.6

225

1357

R81

ICPC

Pneumonia

3.9

14.5

119

J01CA04

ATC

amoxicillin; systemic

2.4

14.5

611

5129

N06AX26

ATC

vortioxetine; oral

2.8

14.5

289

R03DX09

ATC

mepolizumab; parenteral

153.0

14.5

R1250

NOMESCO Finland

Evaluation of functional capability

4.4

14.5

R06AX27

ATC

desloratadine; oral

1.9

14.5

250

1565

-44

ICPC

Preventive immunization/medic

2.8

14.4

284

C08DA01

ATC

verapamil; systemic

3.7

14.4

134

R4110, ,

SPAT

2.3

14.4

128

626

Z02.7

ICD-10 Finland

Issue of medical certificate

2.8

14.4

308

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.4

14.4

113

524

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

11.7

14.4

SPAT1252

SPAT

Overall medication plan or its review

3.0

14.4

228

A07DA03

ATC

loperamide; oral

4.1

14.3

102

WVA30, ,

SPAT

2.9

14.3

251

D72.1

ICD-10 Finland

Eosinophilia

22.8

14.3

C01DA14

ATC

isosorbide mononitrate; oral

2.4

14.3

107

486

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

14.2

189

1081

WX213

NOMESCO Finland

Lower leg blockade

14.8

14.1

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

5.6

14.1

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

14.1

213

1273

UKC02

NOMESCO Finland

Cystoscopy

2.3

14.1

124

604

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.3

14.0

122

591

SPAT1097

SPAT

Recording of ECG

2.3

14.0

123

598

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

5.4

14.0

UDM02

NOMESCO Finland

Sinoscopy

4.4

14.0

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.2

14.0

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

30.7

13.9

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

30.7

13.9

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.9

13.9

249

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

13.9

426

K29.7

ICD-10 Finland

Gastritis, unspecified

3.7

13.9

123

L20

ICPC

Joint symptom/complaint NOS

3.5

13.8

143

ZY010

NOMESCO Finland

Hospital outpatient

3.0

13.7

217

M05BB03

ATC

alendronic acid and colecalciferol; oral

5.3

13.7

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.6

13.7

334

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.0

13.7

223

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

13.7

119

576

WX402

NOMESCO Finland

General anaesthesia

2.0

13.7

196

1148

WX780

NOMESCO Finland

Remote monitoring CPAP

3.3

13.6

170

120

Kela drug reimbursment

Hypogammaglobulinaemia

34.8

13.5

L86

ICPC

Back syndrome with radiating pain

2.9

13.5

247

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

5.4

13.5

N02BE01

ATC

paracetamol; systemic, rectal

2.9

13.5

656

5735

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.5

13.5

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.4

13.4

440

R49.08

ICD-10 Finland

Other specified dysphonia

4.3

13.4

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

6.5

13.3

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.0

13.3

221

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

5.9

13.3

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.7

13.3

297

R01AC01

ATC

cromoglicic acid; nasal

3.5

13.2

137

NG1DA

NOMESCO Finland

X-ray of knees

5.1

13.2

R60.1

ICD-10 Finland

Generalized oedema

12.5

13.2

N04BC05

ATC

pramipexole; oral

2.7

13.1

293

XKD00

NOMESCO Finland

Uroflowmetry

2.3

13.1

105

491

K50.0

ICD-10 Finland

Crohn disease of small intestine

5.4

13.0

S29

ICPC

Skin symptom/complaint other

2.0

13.0

172

978

RS221, ,

NOMESCO Finland

5.7

13.0

PAW37

NOMESCO Finland

Biopsy of temporal artery

23.0

12.9

B01AF02

ATC

apixaban; oral

2.3

12.9

107

507

XF600

NOMESCO Finland

Bloodpressure measurement

2.9

12.9

242

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

12.8

434

3302

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.4

12.8

145

C09CA06

ATC

candesartan; oral

1.9

12.8

200

1203

M54.6

ICD-10 Finland

Pain in thoracic spine

2.6

12.8

327

R06AX22

ATC

ebastine; oral

2.0

12.8

154

846

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

12.7

116

572

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

6.1

12.7

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

3.2

12.6

167

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

12.6

251

XQ820

NOMESCO Finland

Exposure to medicinal substance

17.7

12.6

T90

ICPC

Diabetes non-insulin dependent

1.9

12.5

188

1114

SPAT1104

SPAT

Monitoring of emergency patient

3.0

12.5

206

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

12.5

100

466

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

24.8

12.5

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

5.8

12.5

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

12.4

115

570

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.8

12.4

236

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

12.3

128

664

X58

ICD-10 Finland

Exposure to other specified factors

2.1

12.3

132

693

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.9

12.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

12.3

126

650

WX882

NOMESCO Finland

High dependency care

4.1

12.3

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.3

12.3

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

5.3

12.3

N02AJ13

ATC

tramadol and paracetamol; systemic

4.2

12.2

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

12.1

200

1222

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

12.1

151

839

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

12.0

306

A02BA04

ATC

nizatidine; systemic

2.7

12.0

252

S01

ICPC

Pain/tenderness of skin

3.2

11.9

157

101

Kela drug reimbursment

Anterior pituitary hypofunction

12.0

11.9

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.9

11.9

218

R42

ICD-10 Finland

Dizziness and giddiness

1.9

11.8

183

1094

J01CF05

ATC

flucloxacillin; systemic

2.6

11.8

284

M03BX01

ATC

baclofen; systemic

4.6

11.8

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

4.7

11.7

M05BA06

ATC

ibandronic acid; systemic

4.7

11.7

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

4.9

11.7

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

16.7

11.7

S81.0

ICD-10 Finland

Open wound of knee

5.6

11.7

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.9

11.7

180

1073

N05CF02

ATC

zolpidem; oral

2.0

11.6

149

834

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.4

11.6

361

3027

Kela drug reimbursment

Benralizumab

66.1

11.6

R03DX10

ATC

benralizumab; systemic

66.1

11.6

L04AC07

ATC

tocilizumab; parenteral

66.1

11.6

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.3

11.6

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

19.3

11.6

J01

ICD-10 Finland

Acute sinusitis

2.8

11.6

227

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.8

11.5

A10AC01

ATC

insulin (human); parenteral

2.6

11.5

281

C09CA01

ATC

losartan; oral

1.9

11.5

196

1206

N06AB04

ATC

citalopram; systemic

1.9

11.5

169

991

J96.1

ICD-10 Finland

Chronic respiratory failure

4.9

11.5

N06AB05

ATC

paroxetine; oral

2.8

11.5

222

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.7

11.5

100

ZXE00

NOMESCO Finland

One hour or less

1.7

11.4

299

2089

E000006, ,

ATC

2.6

11.4

276

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.3

11.4

140

ZZA00

NOMESCO Finland

Split skin graft

4.2

11.4

WX002

NOMESCO Finland

Sedation and analgesia

2.0

11.4

154

878

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

4.4

11.3

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

11.3

445

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

3.7

11.3

101

D07AC13

ATC

mometasone; topical

1.8

11.3

225

1452

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

11.3

309

2185

R52.0

ICD-10 Finland

Acute pain

3.3

11.3

136

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.9

11.3

L29.9

ICD-10 Finland

Pruritus, unspecified

3.8

11.2

SPAT1360

SPAT

Extensive global examination

2.9

11.2

202

M35.3

ICD-10 Finland

Polymyalgia rheumatica

3.2

11.2

142

M10.9

ICD-10 Finland

Gout, unspecified

2.8

11.2

208

R05

ICPC

Cough

1.8

11.1

210

1332

A11CC03

ATC

alfacalcidol; systemic

4.4

11.1

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.7

11.1

244

JN4BD

NOMESCO Finland

Extensive body CT

2.4

11.1

376

L60.0

ICD-10 Finland

Ingrowing nail

3.0

11.0

181

R03BC01

ATC

cromoglicic acid; inhalant

4.9

11.0

N05BA06

ATC

lorazepam; systemic, sublingual

2.9

11.0

198

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

14.2

11.0

S92.3

ICD-10 Finland

Fracture of metatarsal bone

3.3

11.0

128

S21

ICPC

Skin texture symptom/complaint

2.0

10.9

128

693

R55

ICD-10 Finland

Syncope and collapse

2.3

10.9

425

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

12.2

10.9

AN1

Coronary angiography

2.4

10.9

346

D02AX

ATC

Other emollients and protectives

3.7

10.9

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.3

10.8

129

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

4.4

10.8

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

5.2

10.8

R06.2

ICD-10 Finland

Wheezing

3.1

10.8

150

B03XA02

ATC

darbepoetin alfa; parenteral

4.8

10.8

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.8

10.8

212

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

10.8

427

N06AA10

ATC

nortriptyline; systemic

4.0

10.8

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

5.7

10.7

E23.00

ICD-10 Finland

Panhypopituitarism

21.8

10.7

L99

ICPC

Musculoskeletal disease other

4.2

10.7

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.3

10.7

125

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

10.7

141

796

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.9

10.7

161

951

251, ,

Kela drug reimbursment

60.9

10.6

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

11.4

10.6

SPAT1131

SPAT

Colonoscopy

3.7

10.6

L29

ICPC

Musculoskeletal sympt/complt other

2.3

10.6

383

M03BX02

ATC

tizanidine; oral

1.7

10.6

464

3704

M45

ICD-10 Finland

Ankylosing spondylitis

4.1

10.6

TK800

NOMESCO Finland

Hemodialysis

5.1

10.6

A08

ICPC

Swelling

2.7

10.6

226

D01AE15

ATC

terbinafine; topical

2.6

10.6

250

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.7

10.5

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.5

10.4

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

5.5

10.4

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.3

10.4

S22.3

ICD-10 Finland

Fracture of rib

2.6

10.4

264

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

10.4

264

F43.29

ICD-10 Finland

Adaptation disorder UNS

3.9

10.4

L16

ICPC

Ankle symptom/complaint

2.1

10.4

109

566

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

12.3

10.4

RS222, ,

NOMESCO Finland

8.4

10.4

ZX100

NOMESCO Finland

Oral

5.2

10.4

RS142, ,

NOMESCO Finland

33.1

10.4

D11AH05

ATC

dupilumab; topical

33.1

10.4

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

4.5

10.3

B35.3

ICD-10 Finland

Tinea pedis

3.0

10.3

160

XQ845

NOMESCO Finland

Dermatoscopy

4.8

10.3

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.8

10.3

Z01.2

ICD-10 Finland

Dental examination

1.7

10.2

357

2672

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

10.2

436

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.4

10.2

317

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

10.2

261

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

5.4

10.2

SBB10

NOMESCO Finland

Dental impressions

2.5

10.2

286

C08CA02

ATC

felodipine; oral

2.4

10.1

312

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

3.0

10.1

151

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

4.6

10.1

Z94.0

ICD-10 Finland

Kidney transplant status

9.3

10.1

R5110, ,

SPAT

2.3

10.0

365

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.7

10.0

A02BX02

ATC

sucralfate; oral

3.2

10.0

125

104

Kela drug reimbursment

Thyroid insufficiency

2.5

10.0

263

SCA02

NOMESCO Finland

Preventive oral health care

2.2

10.0

461

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.2

10.0

461

R1250, ,

SPAT

3.5

10.0

105

SPAT1057

SPAT

Peak expiratory flow measurement

4.2

10.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

10.0

110

582

N03AG01

ATC

valproic acid; systemic, rectal

2.6

10.0

233

XA800

NOMESCO Finland

Neuropsychological investigation

3.0

9.9

158

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

8.3

9.9

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

9.9

216

XW000

NOMESCO Finland

Bone marrow biopsy

3.3

9.9

116

N19

ICD-10 Finland

Unspecified kidney failure

3.3

9.9

116

OAB43, ,

SPAT

0.5

9.8

1615

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.6

9.8

R03BB07

ATC

umeclidinium bromide; inhalant

10.8

9.8

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.9

9.8

176

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

9.8

323

G43.3

ICD-10 Finland

Complicated migraine

4.2

9.8

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

9.8

267

1869

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

7.5

9.8

SPAT1202

SPAT

Intra-articular injection

3.6

9.7

M04AA01

ATC

allopurinol; systemic

2.2

9.7

438

A10BJ02

ATC

liraglutide; parenteral

3.5

9.7

XKC03

NOMESCO Finland

Water cystometry

3.5

9.7

102

J01DA01

ATC

[U] cefalexin

1.7

9.7

444

3546

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

5.4

9.7

XX2RW, ,

NOMESCO Finland

5.4

9.7

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

55.8

9.7

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.2

9.7

128

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.2

9.6

123

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

5.1

9.6

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.1

9.6

A10BJ06

ATC

semaglutide; parenteral

2.7

9.6

213

K07

ICPC

Swollen ankles/oedema

2.9

9.6

161

SPAT1240

SPAT

Therapeutic discussion

2.2

9.6

440

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

9.6

527

4411

QXB99, ,

SPAT

3.6

9.6

M01AX01

ATC

nabumetone; oral

3.0

9.5

145

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

7.7

9.5

J33.0

ICD-10 Finland

Polyp of nasal cavity

3.6

9.4

D84.18

ICD-10 Finland

Other specified defect in the complement system

101.3

9.4

395

Kela drug reimbursment

Dupilumab

30.5

9.4

S06

ICPC

Rash localized

2.8

9.4

186

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.8

9.4

186

RJ630, ,

NOMESCO Finland

+∞

9.4

RF410, ,

NOMESCO Finland

8.8

9.3

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

10.9

9.3

TKC22

NOMESCO Finland

Catheterisation instruction

4.1

9.3

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

9.7

9.3

R05

ICD-10 Finland

Cough

1.8

9.3

171

1069

J05AB11

ATC

valaciclovir; oral

1.9

9.3

127

723

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

9.3

235

ZYC01, ,

SPAT

2.2

9.3

425

N05CD07

ATC

temazepam; oral

2.2

9.3

432

R33

ICD-10 Finland

Retention of urine

2.6

9.3

229

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.4

9.2

S19

ICPC

Skin injury other

3.1

9.2

132

B81

ICPC

Anaemia vit B12/folate deficiency

3.3

9.2

111

L50.0

ICD-10 Finland

Allergic urticaria

3.6

9.2

N03AX11

ATC

topiramate; oral

3.5

9.1

RD210, ,

NOMESCO Finland

4.5

9.1

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.1

9.1

WX720

NOMESCO Finland

Own respiration

2.7

9.1

189

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.7

9.1

195

J20

ICD-10 Finland

Acute bronchitis

2.1

9.1

478

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

9.1

172

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.8

9.1

172

205

Kela drug reimbursment

Chronic hypertension

1.8

9.1

165

1028

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

10.2

9.1

C08CA13

ATC

lercanidipine; oral

2.0

9.1

111

609

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

9.1

238

J01DA09

ATC

[U] cefadroxil

1.7

9.0

194

1267

A03CA02

ATC

clidinium and psycholeptics; oral

2.7

9.0

184

A12BA01

ATC

potassium chloride; oral

3.3

9.0

102

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

9.0

107

581

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.1

9.0

123

N29

ICPC

Neurological sympt/complt other

4.3

9.0

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

9.0

239

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

18.9

9.0

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.7

8.9

185

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.5

8.9

252

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

24.4

8.9

M54.1

ICD-10 Finland

Radiculopathy

3.0

8.9

140

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.4

8.9

291

R49.01

ICD-10 Finland

Functional dysphonia

3.1

8.9

124

-50

ICPC

Medication/prescr/renewal

3.1

8.9

124

WVA20

NOMESCO Finland

Medicine administration

3.4

8.9

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

8.9

209

1400

G44.2

ICD-10 Finland

Tension-type headache

1.9

8.9

118

666

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.4

8.9

R09

ICPC

Sinus symptom/complaint

2.2

8.8

385

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

10.9

8.8

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.9

8.8

152

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

7.3

8.8

OAB72

NOMESCO Finland

Weight control and weight loss guidance

7.3

8.8

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

7.3

8.8

Z01.9

ICD-10 Finland

Special examination, unspecified

2.4

8.8

267

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.9

8.8

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

8.7

147

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

8.7

130

761

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.4

8.7

SPAT1139

SPAT

Nutrition survey

3.4

8.7

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

8.7

450

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

8.7

491

4078

L01XX23

ATC

mitotane; oral

50.6

8.7

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.3

8.7

320

L50.9

ICD-10 Finland

Urticaria, unspecified

2.9

8.7

142

N06AX12

ATC

bupropion; oral

2.3

8.6

288

B02.9

ICD-10 Finland

Zoster without complication

2.4

8.6

256

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.9

8.6

JAH01

NOMESCO Finland

Laparoscopy

2.7

8.6

171

L04AB06

ATC

golimumab; parenteral

8.4

8.6

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

8.4

8.6

A10BK03

ATC

empagliflozin; oral

2.1

8.6

445

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

8.6

417

WX212

NOMESCO Finland

Femoral plexus blockade

3.9

8.6

M05BA01

ATC

etidronic acid; systemic

16.5

8.6

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

16.5

8.6

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

3.4

8.6

ZXC50

NOMESCO Finland

Cryotherapy

3.4

8.6

J05AH02

ATC

oseltamivir; oral

10.2

8.6

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

8.5

178

1151

E27.0

ICD-10 Finland

Other adrenocortical overactivity

27.9

8.5

Z93

ICD-10 Finland

Artificial opening status

20.3

8.5

256, ,

Kela drug reimbursment

20.3

8.5

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

7.5

8.5

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.0

8.5

133

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.3

8.5

101

E24.2

ICD-10 Finland

Drug-induced Cushing syndrome

91.1

8.4

J01GB01

ATC

tobramycin; inhalant, parenteral

91.1

8.4

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.4

8.4

240

F61.0

ICD-10 Finland

Mixed personality disorders

4.5

8.4

RF420, ,

NOMESCO Finland

6.8

8.4

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

8.0

8.4

SPAT1304

SPAT

Counselling and guidance related to ageing

2.5

8.4

234

K76.9

ICD-10 Finland

Liver disease, unspecified

5.0

8.4

B35.4

ICD-10 Finland

Tinea corporis

4.7

8.4

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.7

8.4

C03AA03

ATC

hydrochlorothiazide; oral

2.3

8.3

293

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.2

8.3

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.3

8.3

287

Z2446

NOMESCO Finland

Social worker

2.3

8.2

275

WZC30, ,

SPAT

2.2

8.2

355

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

7.7

8.2

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

4.4

8.2

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.7

8.2

164

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

8.2

178

1163

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.6

8.2

N06AX18

ATC

reboxetine; oral

4.8

8.1

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.0

8.1

125

G72.9

ICD-10 Finland

Myopathy, unspecified

8.3

8.1

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

8.3

8.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.1

8.1

L26

ICD-10 Finland

Exfoliative dermatitis

33.8

8.1

E27.8

ICD-10 Finland

Other specified disorders of adrenal gland

33.8

8.1

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

17.4

8.1

J01DA08

ATC

[U] cefaclor

2.1

8.1

427

R13

ICD-10 Finland

Dysphagia

2.3

8.0

284

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

22.3

8.0

K59.0

ICD-10 Finland

Constipation

2.5

8.0

208

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.2

8.0

325

J33.8

ICD-10 Finland

Other polyp of sinus

4.0

7.9

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.2

7.9

100

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.7

7.9

H57.1

ICD-10 Finland

Ocular pain

2.7

7.9

167

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

13.2

7.9

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

6.2

7.9

K02.1

ICD-10 Finland

Caries of dentine

1.6

7.9

428

3480

A01AB10

ATC

natamycin; local oral

3.3

7.9

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

7.9

267

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

7.9

320

SPAT1058

SPAT

PEF monitoring instruction

2.2

7.9

300

G62.8

ICD-10 Finland

Other specified polyneuropathies

8.6

7.8

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

8.6

7.8

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

7.8

178

1175

K92.1

ICD-10 Finland

Melaena

2.7

7.8

162

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.1

7.8

106

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

11.0

7.8

SPAT1059

SPAT

Spirometry at the office

2.6

7.8

180

SXC05

NOMESCO Finland

Other oral or dental procedure

2.3

7.8

281

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

9.5

7.8

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

9.5

7.8

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.2

7.8

308

I50.0

ICD-10 Finland

Congestive heart failure

2.5

7.8

211

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.3

7.8

W17

ICD-10 Finland

Other fall from one level to another

3.0

7.8

112

R04.0

ICD-10 Finland

Epistaxis

2.3

7.7

269

L04AB05

ATC

certolizumab pegol; parenteral

15.2

7.7

J96.0

ICD-10 Finland

Acute respiratory failure

6.0

7.7

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

6.0

7.7

M79.1

ICD-10 Finland

Myalgia

1.8

7.7

126

757

WZB00, ,

SPAT

2.2

7.7

343

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.1

7.7

107

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.9

7.7

129

S86.0

ICD-10 Finland

Injury of Achilles tendon

3.8

7.7

J01DC02

ATC

cefuroxime; systemic

2.5

7.7

200

K30

ICD-10 Finland

Functional dyspepsia

1.9

7.7

537

N06AB06

ATC

sertraline; oral

1.9

7.6

545

J05AB01

ATC

aciclovir; systemic

1.7

7.6

170

1116

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

18.6

7.6

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

18.6

7.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

7.6

521

4455

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.1

7.6

359

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.9

7.6

130

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

6.3

7.6

N18.8

ICD-10 Finland

Other chronic renal failure

4.2

7.6

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

9.0

7.6

L52

ICD-10 Finland

Erythema nodosum

9.0

7.6

J15.8

ICD-10 Finland

Other bacterial pneumonia

10.2

7.6

EMAK, ,

NOMESCO Finland

3.0

7.5

114

WYA10

NOMESCO Finland

Emergency care or similar visit

2.2

7.5

299

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

3.2

7.5

B34.9

ICD-10 Finland

Viral infection, unspecified

3.2

7.5

A02BA03

ATC

famotidine; systemic

3.2

7.5

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.7

7.5

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.7

7.5

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.7

7.5

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

7.2

7.5

TQW99

NOMESCO Finland

Other minor procedure on skin

2.5

7.5

184

A41.8

ICD-10 Finland

Other specified sepsis

4.0

7.5

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.6

7.5

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.5

7.5

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

7.4

182

1223

N30.9

ICD-10 Finland

Cystitis, unspecified

2.3

7.4

254

A10BA02

ATC

metformin; oral

1.6

7.4

194

1326

N05BA12

ATC

alprazolam; oral

2.0

7.4

419

E86

ICD-10 Finland

Volume depletion

3.8

7.4

R30.0

ICD-10 Finland

Dysuria

2.6

7.4

161

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.1

7.4

C10AX09

ATC

ezetimibe; oral

1.8

7.4

124

751

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

7.4

456

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.5

7.3

192

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

7.3

217

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

3.2

7.3

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

11.0

7.3

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.0

7.3

105

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.7

7.3

156

QDA10

NOMESCO Finland

Incision of skin of lower limb

9.5

7.3

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

9.5

7.3

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

9.5

7.3

XG466

NOMESCO Finland

Sleep oxymetry

3.4

7.3

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

3.9

7.3

A10BK01

ATC

dapagliflozin; oral

2.2

7.3

296

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

7.3

276

R06.5

ICD-10 Finland

Mouth breathing

2.1

7.3

351

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.8

7.3

118

707

ZX120, ,

SPAT

6.3

7.3

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

6.3

7.3

J37.0

ICD-10 Finland

Chronic laryngitis

2.9

7.3

122

D09AB01

ATC

zinc bandage without supplements; topical

4.4

7.2

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.4

7.2

NDG71

NOMESCO Finland

Arthrodes of first MP joint

15.9

7.2

R5120

NOMESCO Finland

Preparation of an aid

3.1

7.2

H26.4

ICD-10 Finland

After-cataract

2.1

7.2

373

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.6

7.2

169

L08

ICPC

Shoulder symptom/complaint

1.7

7.2

174

1164

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

7.4

7.2

K93

ICPC

Pulmonary embolism

7.4

7.2

B37.08

ICD-10 Finland

Other candidal stomatitis

7.4

7.2

E83.50

ICD-10 Finland

Hypercalcemia

4.6

7.2

R06AX18

ATC

acrivastine; oral

3.2

7.2

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

3.6

7.2

K08.3

ICD-10 Finland

Retained dental root

2.2

7.2

291

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.8

7.2

134

P03

ICPC

Feeling depressed

2.0

7.2

431

N06AB10

ATC

escitalopram; oral

1.7

7.2

157

1024

B01AC04

ATC

clopidogrel; oral

1.8

7.2

107

625

288

Kela drug reimbursment

Febuxostat

30.3

7.2

M04AA03

ATC

febuxostat; oral

30.3

7.2

349

Kela drug reimbursment

Febuxostat

30.3

7.2

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

30.3

7.2

Angiography of the heart and coronary arteries

2.6

7.1

158

J01.1

ICD-10 Finland

Acute frontal sinusitis

3.8

7.1

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

7.1

102

588

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

6.1

7.1

H26.2

ICD-10 Finland

Complicated cataract

5.7

7.1

132

Kela drug reimbursment

Sarcoidosis

8.9

7.1

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

8.9

7.1

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.9

7.1

492

R04.2

ICD-10 Finland

Haemoptysis

3.2

7.1

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

10.2

7.1

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.9

7.0

113

XA402

NOMESCO Finland

ENMG

3.3

7.0

RF120, ,

NOMESCO Finland

7.1

7.0

R4120

NOMESCO Finland

Occupational therapy

2.2

7.0

274

B07.9

ICD-10 Finland

Verruca simplex

2.9

7.0

119

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

7.0

203

Z2445

NOMESCO Finland

Psychologist

2.7

7.0

148

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.6

7.0

154

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.1

7.0

XG405

NOMESCO Finland

Education on PEF monitoring

5.5

7.0

WX730

NOMESCO Finland

Conventional respirator

5.9

6.9

A06AH03

ATC

naloxegol; oral

5.9

6.9

HAHOM, ,

NOMESCO Finland

5.9

6.9

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

7.6

6.9

L50.3

ICD-10 Finland

Dermatographic urticaria

3.6

6.9

134

Kela drug reimbursment

General erythroderma

13.9

6.9

S76

ICPC

Skin infection other

2.4

6.9

204

SFA10

NOMESCO Finland

One-surface restoration

1.5

6.9

397

3228

J01FA01

ATC

erythromycin; systemic

1.9

6.9

541

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.4

6.9

R5599

NOMESCO Finland

Other rehabilitation service

3.0

6.9

E000007, ,

ATC

2.4

6.9

198

L13

ICPC

Hip symptom/complaint

1.7

6.9

147

952

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.8

6.9

126

N05CD02

ATC

nitrazepam; oral

4.2

6.8

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.9

6.8

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.0

6.8

104

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

11.1

6.8

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

11.1

6.8

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.3

6.8

218

K12.18

ICD-10 Finland

Other forms of stomatitis

9.4

6.8

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

5.7

6.8

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

4.3

6.8

L30.4

ICD-10 Finland

Erythema intertrigo

4.3

6.8

R95

ICPC

Chron obstructive pulmonary disease

3.2

6.8

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

40.4

6.8

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

40.4

6.8

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

40.4

6.8

8370/3-C74.0

ICD-O-3

Adrenal cortical carcinoma of cortex of adrenal gland

40.4

6.8

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

40.4

6.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

6.8

253

1874

D05BB02

ATC

acitretin; oral

3.6

6.8

RS130, ,

NOMESCO Finland

16.9

6.8

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

4.0

6.7

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.4

6.7

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.7

6.7

133

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

6.7

173

1174

D07XC01

ATC

betamethasone; topical

1.9

6.7

485

D11AH01

ATC

tacrolimus; topical

7.3

6.7

W19

ICD-10 Finland

Unspecified fall

2.0

6.7

383

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

6.7

122

756

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

22.8

6.7

ND2CG

NOMESCO Finland

Extensive MRI of hand

22.8

6.7

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.8

6.7

D06BX01

ATC

metronidazole; topical

1.9

6.7

479

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

6.5

6.7

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.1

6.7

A29

ICPC

General symptom/complaint other

1.8

6.6

104

616

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.6

6.6

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

7.9

6.6

JN4CD

NOMESCO Finland

Very extensive body CT

3.0

6.6

N06AA12

ATC

doxepin; systemic

2.4

6.6

202

EBA00

NOMESCO Finland

Extraction of tooth

1.5

6.6

258

1928

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.1

6.6

295

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

8.8

6.6

M02AA07

ATC

piroxicam; topical

1.5

6.6

243

1794

R01AC07

ATC

nedocromil; nasal

10.1

6.5

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

6.5

235

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.4

6.5

190

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.2

6.5

242

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.7

6.5

J01CA08

ATC

pivmecillinam; oral

1.5

6.5

300

2319

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.1

6.5

331

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

5.4

6.5

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

6.5

203

1442

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

3.0

6.5

UJG02

NOMESCO Finland

Proctoscopy

3.6

6.5

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

3.6

6.5

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.3

6.5

SFA30

NOMESCO Finland

Three-surface restoration

1.5

6.5

308

2396

R07.2

ICD-10 Finland

Precordial pain

4.0

6.5

C05AA08

ATC

fluocortolone; rectal, topical

1.8

6.5

100

590

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.7

6.5

136

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.7

6.5

136

NH1AD

NOMESCO Finland

Ankle and foot CT

3.5

6.5

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.8

6.5

113

-1, ,

NOMESCO Finland

1.5

6.5

241

1781

R75

ICPC

Sinusitis acute/chronic

2.3

6.5

204

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.3

6.4

230

C01AA05

ATC

digoxin; systemic

2.4

6.4

185

M30.8

ICD-10 Finland

Other conditions related to polyarteritis nodosa

70.5

6.4

RK112, ,

NOMESCO Finland

70.5

6.4

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

70.5

6.4

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

14.5

6.4

3042, ,

Kela drug reimbursment

14.5

6.4

253, ,

Kela drug reimbursment

14.5

6.4

ZXD00

NOMESCO Finland

Emergency procedure

3.1

6.4

L14

ICPC

Leg/thigh symptom/complaint

2.0

6.4

340

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

3.8

6.4

S01GX04

ATC

nedocromil; ophthalmic

3.8

6.4

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

4.1

6.4

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

6.4

H26.02

ICD-10 Finland

Presenil cataract

3.0

6.4

Z50.1

ICD-10 Finland

Other physical therapy

2.4

6.4

186

IHZ05, ,

SPAT

2.6

6.4

149

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

6.4

108

655

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.4

6.4

180

R68.2

ICD-10 Finland

Dry mouth, unspecified

8.3

6.4

L04AC05

ATC

ustekinumab; parenteral

8.3

6.4

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

8.3

6.4

GX2D5

NOMESCO Finland

Sleep oximetry

8.3

6.4

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

8.3

6.4

U04

ICPC

Incontinence urine

2.3

6.3

212

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.2

6.3

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

6.3

390

3192

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.0

6.3

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

6.0

6.3

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.3

6.3

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

11.1

6.3

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.5

6.3

162

L30.3

ICD-10 Finland

Infective dermatitis

2.7

6.3

132

XF404

NOMESCO Finland

Ambulatory ECG

2.0

6.3

328

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.6

6.3

138

L19

ICPC

Muscle symptom/complaint NOS

3.1

6.3

C07AA05

ATC

propranolol; systemic

1.6

6.3

153

1023

RS314, ,

NOMESCO Finland

18.2

6.3

R03DX11

ATC

tezepelumab; systemic

+∞

6.3

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

6.2

294

SFA20

NOMESCO Finland

Two-surface restoration

1.5

6.2

421

3506

HMAK, ,

NOMESCO Finland

1.9

6.2

498

M01AH02

ATC

rofecoxib; oral

1.8

6.2

536

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.0

6.2

NF1DA

NOMESCO Finland

X-ray of hips

3.3

6.2

A10BJ05

ATC

dulaglutide; parenteral

3.4

6.2

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.8

6.2

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.0

6.2

R01AC02

ATC

levocabastine; nasal

3.0

6.2

D94

ICPC

Chronic enteritis/ulcerative colitis

7.8

6.1

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.8

6.1

L20.0

ICD-10 Finland

Besnier prurigo

2.1

6.1

310

H53.2

ICD-10 Finland

Diplopia

2.8

6.1

105

M54.3

ICD-10 Finland

Sciatica

2.2

6.1

242

3007

Kela drug reimbursment

Erenumab and fremanezumab

4.2

6.1

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.2

6.1

SPAT1285

SPAT

Provision of consultation response

2.4

6.1

177

D11

ICPC

Diarrhoea

1.8

6.1

554

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

12.7

6.1

WX704

NOMESCO Finland

Intubation

2.0

6.1

332

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

8.7

6.1

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

3.7

6.1

L03.9

ICD-10 Finland

Cellulitis, unspecified

3.7

6.1

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.5

6.1

159

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

6.8

6.1

WX308

NOMESCO Finland

Sacral anesthesy

10.1

6.0

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

10.1

6.0

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

6.0

327

2601

NDG76

NOMESCO Finland

Fusion of DIP joint

6.1

6.0

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

6.1

6.0

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

5.6

6.0

S20.2

ICD-10 Finland

Contusion of thorax

2.4

6.0

172

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.9

6.0

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

3.9

6.0

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

6.0

348

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3036481) Cortisol [Moles/volume] in Serum or Plasma

604

674

53.90

307.65

7.3

2.1

178.15

374.97

nmol/l

71.99

585

636

(3017181) Myelocytes/Leukocytes in Blood

315

596

8.69

176.77

8.3

5.0

0.88

1.00

0.32

137

191

(3002179) Metamyelocytes/Leukocytes in Blood

303

571

8.50

169.92

7.7

4.9

0.61

0.58

0.07

128

175

(3021440) Promyelocytes/Leukocytes in Blood

295

564

8.23

162.46

8.7

5.1

0.12

0.13

0.05

117

159

(3025159) Blasts/Leukocytes in Blood

297

580

8.08

160.09

9.1

5.3

0.03

0.16

1.04

111

146

(3005719) IgG [Mass/volume] in Serum or Plasma

270

562

7.13

134.31

5.5

3.0

9.18

10.42

g/l

4.93

255

532

(3011985) Renin [Units/volume] in Plasma

122

15.80

132.94

2.9

1.2

58.43

65.00

mu/l

0.07

107

(40760892) CBC W Ordered Manual Differential panel - Blood

435

1515

5.82

120.23

13.9

5.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

240

501

6.72

117.53

2.7

1.3

461.05

208.66

u/ml

0.82

229

469

(3023368) Bacteria identified in Blood by Culture

457

1690

5.77

116.65

9.0

4.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

220

460

6.48

106.66

2.5

1.8

1.08

1.30

g/l

1.46

211

426

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

228

499

6.25

105.25

6.7

4.0

1.22

1.23

mmol/l

0.83

216

433

(3035715) Granulocytes [#/volume] in Blood

115

11.74

104.53

4.5

3.3

5.00

4.30

e9/l

1.53

115

(3004789) Transferrin [Mass/volume] in Serum or Plasma

321

995

5.06

98.27

3.5

2.6

2.38

2.33

g/l

0.76

304

926

(3001604) Monocytes [#/volume] in Blood

635

3393

9.15

98.26

18.1

6.5

0.66

0.57

e9/l

16.12

621

2895

(3006315) Basophils [#/volume] in Blood

633

3399

8.86

96.56

18.2

6.5

0.04

e9/l

2.48

620

2902

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

212

469

6.02

95.99

2.9

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

305

922

5.04

95.98

3.6

2.6

20.48

22.69

1.79

285

864

(3022948) Iron [Moles/volume] in Serum or Plasma

331

1075

4.89

95.01

3.7

2.6

11.48

13.07

umol/l

3.60

312

1004

(4062490) Immunoglobulin typing, IgG

15.39

94.49

2.1

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

635

3455

8.84

94.34

18.3

6.6

1.87

1.95

e9/l

0.99

622

3036

(3013115) Eosinophils [#/volume] in Blood

641

3522

9.33

94.08

18.7

6.8

0.18

0.19

e9/l

1.66

626

3071

(3035933) Granulocytes/Leukocytes in Blood

123

155

9.39

94.05

4.7

3.1

60.17

57.39

1.06

123

155

(3027135) IgG subclass 1 [Mass/volume] in Serum

15.48

92.70

2.0

1.4

6.02

6.57

g/l

0.47

(3028192) IgG subclass 2 [Mass/volume] in Serum

15.48

92.70

2.0

1.4

2.33

2.72

g/l

0.79

(3024139) IgG subclass 3 [Mass/volume] in Serum

15.48

92.70

2.0

1.4

0.36

g/l

0.00

(3024561) Albumin [Mass/volume] in Serum or Plasma

566

2818

5.95

92.41

11.9

5.2

34.02

35.94

g/l

14.17

548

2660

(3018418) pH of Serum or Plasma

457

1950

4.76

90.49

8.1

4.1

7.40

3.64

384

1376

(1616796) Gas panel - Central venous blood

112

134

9.73

89.02

6.1

3.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

412

1646

4.57

88.66

4.0

2.3

3.39

2.86

mg/l

4.45

382

1429

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

320

1069

4.62

87.28

3.6

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

604

3259

6.67

86.96

17.6

7.7

1.21

mmol/l

1.96

507

2844

(3023419) Bacteria identified in Sputum by Culture

12.00

86.41

5.8

2.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

462

2045

4.60

85.56

5.6

2.6

54.67

65.79

u/l

1.46

443

1899

(3012095) Magnesium [Moles/volume] in Serum or Plasma

321

1093

4.53

84.97

6.4

3.9

0.81

0.82

mmol/l

0.64

310

1044

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

129

195

7.86

84.38

2.3

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

158

298

6.53

83.79

1.4

1.2

1.72

1.61

u/ml

0.02

(3024980) IgG subclass 4 [Mass/volume] in Serum

110

10.17

81.54

2.0

1.9

0.50

0.80

g/l

1.02

(3019069) Monocytes/Leukocytes in Blood

582

3149

5.67

80.45

18.8

6.7

8.68

8.71

0.10

576

2961

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

127

199

7.55

80.29

2.3

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

642

3773

8.23

80.18

22.7

10.1

4.99

4.07

e9/l

18.51

630

3281

(3006504) Eosinophils/Leukocytes in Blood

580

3142

5.59

79.70

18.7

6.6

2.42

2.90

5.62

572

2949

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

568

3042

5.31

78.80

5.0

2.6

80.40

76.73

nmol/l

2.67

544

2768

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

13.86

78.06

2.0

1.3

1.31

4.15

u/ml

0.41

(3022096) Basophils/Leukocytes in Blood

576

3135

5.41

77.78

18.9

6.7

0.66

0.70

1.05

569

2934

(3018010) Neutrophils/Leukocytes in Blood

580

3175

5.49

77.70

17.7

6.5

61.05

56.87

14.05

575

3032

(3002030) Lymphocytes/Leukocytes in Blood

583

3211

5.53

77.30

18.9

6.6

25.09

28.36

10.90

577

3054

(3009445) Proteinase 3 Ab [Units/volume] in Serum

147

279

6.38

77.14

1.8

1.5

2.60

13.63

iu/ml

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

262

815

4.51

77.09

3.1

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

226

627

4.82

77.05

6.5

3.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

117

9.33

74.87

2.2

1.6

—

(3026782) Osmolality of Urine

329

1234

4.10

74.37

5.1

2.9

466.25

519.90

mosm/kgh2o

4.49

309

1087

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

252

781

4.45

74.14

3.2

2.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

10.81

73.90

1.5

1.3

461.16

350.59

pmol/l

0.35

(3007853) Bacteria identified in Skin by Aerobe culture

250

775

4.43

73.44

3.0

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

14.69

72.50

2.0

2.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

171

7.59

72.23

2.2

1.5

—

(42870588) Differential panel, method unspecified - Blood

464

2257

4.04

70.53

16.5

6.4

—

(3032080) INR in Blood by Coagulation assay

531

2838

4.44

70.23

26.4

12.7

1.20

inr

0.10

485

2327

(3029937) Albumin [Presence] in Urine by Test strip

415

1889

3.88

69.32

8.4

4.0

0.00

0.01

estimate

1.23

254

668

(3000850) Epithelial cells [#/volume] in Urine

353

1447

3.86

68.98

4.9

2.7

6.03

6.20

e6/l

0.07

338

1323

(3012501) Base excess in Blood by calculation

112

9.06

68.91

7.4

3.2

2.66

2.31

mmol/l

0.53

(3037522) Nuclear Ab [Titer] in Serum

286

1018

4.03

68.75

1.7

1.3

535.38

478.94

titre

0.16

227

(3017732) Neutrophils [#/volume] in Blood

257

849

4.17

68.64

4.1

3.2

4.76

5.15

e9/l

0.24

247

749

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

101

147

7.84

67.83

2.1

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

538

2943

4.40

67.80

16.9

7.3

1.20

1.21

mmol/l

3.92

525

2725

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

584

3418

4.97

66.23

12.7

6.7

9.34

11.79

umol/l

7.43

575

3268

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

170

429

4.89

64.20

4.8

3.5

4.31

4.52

pmol/l

1.99

158

379

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

131

8.02

64.17

1.8

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

608

3711

5.41

64.05

13.2

5.5

6.57

6.65

mmol/l

0.44

599

3533

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

399

1838

3.67

63.97

5.4

3.4

1113.44

1066.17

ng/l

0.06

365

1571

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

141

7.72

63.86

1.8

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

323

1300

3.72

63.86

2.3

1.7

23322005.09

25408784.40

pmol/l

0.03

283

1102

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

124

238

6.10

63.79

1.6

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

100

9.14

63.69

1.9

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

455

2285

3.75

63.61

5.6

3.5

2.31

2.36

mmol/l

8.51

437

2084

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

105

177

6.79

61.44

2.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

127

258

5.78

61.42

3.0

1.8

1.29

2.80

ug/l

0.69

119

234

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

8.98

61.38

2.0

1.6

—

(3042936) Bacteria identified in Isolate by Culture

260

938

3.79

60.05

3.4

2.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

253

899

3.82

59.72

10.7

6.4

1.04

1.06

mmol/l

0.61

245

832

(3021589) Normoblasts [#/volume] in Blood

525

2969

3.94

59.48

36.1

11.4

0.00

0.01

e9/l

0.57

498

2412

(3011412) CD3 cells [#/volume] in Blood

10.48

59.24

1.6

2.2

1361.71

1239.86

e6/l

0.31

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

12.51

59.20

1.9

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

484

2618

3.66

58.31

8.3

3.7

0.01

0.04

estimate

0.96

225

592

(40761536) Microorganisms panel - Urine sediment

181

517

4.36

57.93

8.4

3.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

110

207

6.10

57.54

3.3

2.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

395

1902

3.42

57.14

7.5

3.2

0.10

0.01

estimate

0.46

224

569

(3021387) Prolactin [Units/volume] in Serum or Plasma

115

231

5.75

56.10

1.8

1.5

334.58

272.80

mu/l

2.05

106

215

(3035350) Ketones [Presence] in Urine by Test strip

570

3480

4.22

55.83

8.5

3.9

0.00

2.27

estimate

0.50

263

717

(3016502) Oxygen saturation in Arterial blood

202

641

4.01

55.76

8.3

10.6

95.40

95.70

0.24

196

626

(3025941) Bacteria identified in Stool by Culture

146

363

4.80

55.66

1.6

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

146

7.00

55.66

7.4

6.6

308.14

187.89

iu/ml

0.41

(3002582) Erythrocytes [#/volume] in Urine

416

2100

3.36

55.00

5.8

3.4

77.68

87.65

e6/l

0.06

374

1607

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

211

700

3.86

54.51

5.5

4.5

278.10

251.19

u/l

0.44

203

670

(3009261) Glucose [Presence] in Urine by Test strip

570

3519

4.13

53.96

8.5

3.9

0.00

0.02

estimate

1.46

259

673

(3026008) Bacteria identified in Urine by Culture

400

1995

3.30

53.54

5.2

2.9

—

(3019977) pH of Arterial blood

212

715

3.80

53.34

8.7

10.1

7.43

7.41

2.83

155

404

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

397

1976

3.28

53.23

3.5

2.1

167.88

221.69

u/l

0.64

384

1892

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

212

716

3.79

53.22

8.6

10.0

4.92

5.13

kpa

2.73

206

697

(3027801) Oxygen [Partial pressure] in Arterial blood

212

716

3.79

53.22

8.6

10.0

10.99

12.36

kpa

4.71

205

698

(3001122) Ferritin [Mass/volume] in Serum or Plasma

531

3147

3.71

53.17

5.7

3.1

136.48

108.95

ug/l

1.56

510

2957

(3020630) Protein [Mass/volume] in Serum or Plasma

177

530

4.12

52.75

3.1

3.0

63.91

66.95

g/l

5.19

167

496

(3027945) Reticulocytes/Erythrocytes in Blood

212

725

3.74

52.12

3.6

2.7

1.97

1.81

1.48

188

664

(3021601) Nitrite [Presence] in Urine by Test strip

560

3457

3.92

52.06

8.6

3.9

0.00

estimate

0.50

264

698

(3003396) Base excess in Arterial blood by calculation

209

710

3.75

51.87

8.5

10.1

1.47

0.92

mmol/l

1.21

180

601

(3007164) IgA [Mass/volume] in Serum or Plasma

326

1468

3.25

51.41

2.3

1.5

2.39

2.35

g/l

0.13

269

900

(3009214) Lutropin [Units/volume] in Serum or Plasma

174

6.15

50.91

1.6

1.4

15.39

10.71

u/l

1.42

142

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

12.12

50.53

1.8

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

13.13

49.14

1.9

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

176

550

3.92

49.11

2.9

2.8

75.83

71.67

e9/l

0.67

138

397

(3009343) pH of Capillary blood

161

473

4.11

48.99

8.9

5.3

7.43

7.42

1.81

150

387

(3030467) Casts [#/volume] in Urine by Automated count

367

1808

3.13

48.94

5.4

3.3

0.24

0.40

e6/l

1.65

327

1310

(3030313) Adrenal Ab [Titer] in Serum

112.04

48.48

1.1

1.0

—

titre

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

141

6.53

47.89

3.7

3.1

6.37

8.25

pmol/l

1.14

141

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

12.48

47.64

1.9

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

148

417

4.22

47.59

8.7

5.6

2.64

1.78

mmol/l

2.61

119

320

(3042631) Mycobacterium sp identified in Specimen

8.48

47.53

4.5

2.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

435

2386

3.12

47.45

8.5

3.7

25.60

61.17

ng/l

0.83

367

1655

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

126

6.83

47.23

1.6

1.3

312.50

182.00

titre

—

(3021960) Folate [Moles/volume] in Serum or Plasma

370

1860

3.06

47.10

2.1

1.7

20.62

20.75

nmol/l

0.05

334

1579

(3018095) Leukocytes [#/volume] in Urine

436

2433

3.05

45.39

6.8

4.0

53.84

86.51

e6/l

1.01

382

1694

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

8.35

44.86

1.7

2.0

31.21

33.03

1.87

(3000012) Reticulocyte production index

8.09

44.35

1.8

2.1

1.01

0.92

0.56

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

18.00

43.93

7.2

4.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

316

1507

2.97

43.40

3.3

1.9

1.27

1.20

mg/l

0.14

260

1188

(3021447) Carbon dioxide [Partial pressure] in Venous blood

192

690

3.44

42.85

13.2

4.5

5.88

5.76

kpa

0.84

186

672

(3014576) Chloride [Moles/volume] in Serum or Plasma

224

888

3.22

42.51

11.9

8.0

103.31

104.25

mmol/l

2.06

224

888

(3048689) Calprotectin [Mass/mass] in Stool

229

922

3.19

42.31

5.3

2.5

236.35

112.57

ug/g

2.50

196

741

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

178

615

3.53

42.21

3.2

2.4

0.23

0.21

g/l

2.28

164

582

(36304419) Bacteria [Presence] in Urine

342

1728

2.89

41.81

5.3

3.2

—

0.00

estimate

—

(3004588) Protein electrophoresis panel - Serum or Plasma

145

440

3.88

41.72

3.1

2.4

—

(3000494) Fungus identified in Specimen by Culture

218

862

3.21

41.42

2.3

1.4

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

654

4806

5.50

40.59

13.9

4.5

14.21

11.75

mm/h

5.04

640

4508

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

407

2282

2.83

40.33

6.3

3.4

31.23

32.35

u/l

0.21

381

2161

(3031040) Bacteria [#/volume] in Urine by Automated count

601

4179

3.83

40.16

9.5

4.6

460.71

1629.90

e6/l

0.76

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

113

296

4.35

39.68

3.3

2.3

35.08

39.77

u/l

1.59

107

268

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

189

5.17

39.41

1.7

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

100

243

4.63

38.61

1.8

1.6

0.24

g/l

0.12

235

(3012544) pH of Venous blood

183

688

3.24

37.45

14.3

4.6

7.39

7.38

0.84

132

395

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

101

255

4.45

37.11

1.8

1.6

1.31

1.20

g/l

2.71

247

(3002032) Base excess in Venous blood by calculation

177

661

3.23

36.55

14.0

4.6

2.53

1.75

mmol/l

2.15

164

570

(3003181) Sodium [Moles/volume] in Urine

120

6.06

36.48

1.9

1.5

69.29

62.20

mmol/l

0.59

104

(3026493) Urate [Moles/volume] in Serum or Plasma

319

1644

2.71

36.25

4.3

2.7

324.96

333.72

umol/l

0.79

285

1466

(3004809) Band form neutrophils/Leukocytes in Blood

6.47

34.60

3.2

3.5

0.98

1.31

0.43

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

226

4.47

34.06

1.9

1.6

0.01

0.10

iu/ml

0.93

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

141

5.40

33.59

2.1

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

219

962

2.84

33.55

3.5

2.6

29.59

29.45

0.12

209

938

(3019309) Folate [Moles/volume] in Red Blood Cells

225

1007

2.81

33.22

2.1

1.7

1490.27

1194.58

nmol/l

4.18

168

760

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

120

5.66

32.10

5.2

3.9

88612.83

2863.70

u/ml

—

(3023420) DNA double strand Ab [Units/volume] in Serum

108

319

3.81

31.88

2.1

1.9

5.15

6.34

iu/ml

0.21

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

8.36

31.41

1.3

1.2

—

(3047181) Lactate [Moles/volume] in Blood

168

4.80

30.89

8.4

9.0

1.43

1.30

mmol/l

0.49

151

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

8.31

30.53

1.9

2.3

264.11

226.15

e6/l

0.30

(3026389) Candida sp identified in Specimen by Organism specific culture

6.28

30.37

1.5

1.3

—

(21494814) CD8 cells/Lymphocytes in Specimen

12.48

30.04

1.5

1.6

28.37

30.56

0.22

(3006571) Granulocytes/Leukocytes in Synovial fluid

7.16

30.04

2.2

1.5

58.64

60.32

0.09

(3004451) EKG impression Narrative

8.86

29.87

1.4

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

107

331

3.63

29.41

2.0

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

209

4.25

28.73

2.3

2.1

189.35

517.15

ug/l

0.83

195

(3008295) Osmolality of Serum or Plasma

6.76

28.49

1.4

275.14

278.78

mosm/kgh2o

0.36

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

7.79

28.26

1.7

2.3

497.41

493.55

e6/l

0.01

(3015736) pH of Urine

429

2794

2.35

26.60

6.4

3.5

6.27

6.20

0.65

278

1581

(3017143) Hepatitis C virus Ab [Presence] in Serum

175

763

2.72

26.48

1.9

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

111

5.29

26.25

2.8

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

111

5.29

26.25

2.8

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

111

5.29

26.25

2.8

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

111

5.29

26.25

2.8

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

135

4.85

26.18

1.9

2.0

4.21

4.94

mmol/24h

0.94

122

(3044889) 12 lead EKG panel

585

4422

2.82

25.52

7.0

4.0

—

0.36

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

231

1171

2.44

25.37

2.2

1.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

210

3.99

25.27

5.2

3.7

31.90

74.40

mg/l

0.83

179

(3022145) Colonoscopy Study observation

174

773

2.66

25.24

1.9

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

293

1654

2.31

25.09

1.5

1.3

1.26

1.40

u/ml

0.12

132

436

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

243

1269

2.39

24.89

1.6

1.3

9.10

12.35

u/ml

0.38

120

502

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

6.53

24.70

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

638

5089

3.47

24.52

9.1

4.5

15.15

14.68

pmol/l

4.37

613

4716

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

210

3.93

24.48

5.2

3.7

30.79

39.57

mg/l

0.38

178

(3013512) EKG study

353

2169

2.25

24.47

5.7

3.5

—

0.86

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

257

1384

2.34

24.46

1.6

1.4

20.44

31.04

iu/ml

1.76

106

432

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

243

1282

2.36

24.20

3.9

2.8

2.45

mmol/l

0.12

226

1156

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

8.71

24.17

1.2

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

203

989

2.47

24.16

1.9

1.6

—

(40768443) Skin Pathology biopsy report

287

3.49

24.13

1.7

1.3

—

(3037756) Immunofixation for Serum or Plasma

133

4.66

23.83

1.8

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

421

2804

2.23

23.58

2.5

2.1

89.98

96.92

pmol/l

2.68

268

1465

(3003329) Lymphocytes/Leukocytes in Synovial fluid

7.55

23.50

2.4

1.4

31.23

34.00

0.13

(3000570) Elastase.pancreatic [Mass/mass] in Stool

213

3.82

23.22

1.6

1.4

264.84

299.84

ug/g

0.68

129

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

134

4.54

22.70

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

133

544

2.78

22.49

5.5

4.0

81.70

79.96

ng/l

0.07

111

485

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

9.32

22.20

2.6

1.7

81.54

56.16

ug/l

0.95

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

129

4.54

21.96

1.7

1.4

287.95

252.74

u/ml

0.26

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

121

4.65

21.87

1.6

154.26

148.67

au/ml

0.11

(40768797) Stomach Pathology biopsy report

192

956

2.38

21.46

1.5

1.2

—

(3000991) Gas panel - Venous blood

135

570

2.69

21.39

14.7

10.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

192

3.81

21.20

4.8

3.5

2.17

2.74

ratio

0.26

108

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

5.59

21.13

1.8

1.3

—

nmol/l

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

208

3.68

20.98

1.6

1.3

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

5.75

20.76

1.3

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

6.33

20.00

1.2

112.79

107.13

pmol/l

0.20

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

5.19

19.94

1.6

1.3

0.19

0.18

nmol/l

0.17

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

109

4.65

19.93

1.7

1.4

0.39

0.33

nmol/l

0.34

(3023323) Follitropin [Units/volume] in Serum or Plasma

101

381

2.92

19.73

1.7

1.4

30.35

27.94

iu/l

0.28

328

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

639

5280

3.08

19.47

58.8

19.5

14.40

13.59

32.53

639

5228

(3048929) Epstein Barr virus Ab [Presence] in Serum

214

3.52

19.38

1.7

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

109

434

2.79

19.25

7.3

3.8

118.65

190.16

ng/l

1.31

102

394

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

6.76

18.88

2.7

2.8

39.77

41.12

0.11

(3023183) Ammonium ion [Moles/volume] in Plasma

141

4.06

18.74

2.7

3.4

28.73

34.19

umol/l

1.25

127

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

128

4.21

18.66

1.4

1.5

—

(3017569) Oxygen content in Arterial blood

7.67

18.34

2.4

3.9

15.45

16.92

0.70

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

426

3017

2.03

18.31

4.7

2.8

—

estimate

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

4.99

18.21

1.4

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

157

766

2.35

18.06

4.3

3.0

5.85

7.08

umol/l

0.59

129

675

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

258

3.18

17.79

1.9

2.0

1.75

1.48

g/l

1.15

234

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

103

418

2.71

17.47

16.4

4.8

24.86

24.16

mmol/l

1.55

103

413

(3021879) Hepatitis B virus core Ab [Presence] in Serum

117

511

2.54

17.09

1.4

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

163

3.64

16.67

4.2

6.5

0.35

0.37

iu/ml

0.21

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

15.82

16.29

2.5

3.2

134.74

39.00

au/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

102

429

2.61

16.06

2.9

2.3

11.30

13.11

nmol/l

1.21

400

(3007566) Smooth muscle Ab [Titer] in Serum

194

3.29

15.18

1.4

1.2

197.00

100.42

titre

—

(4035726) Immunohistochemistry procedure

122

574

2.36

15.06

1.6

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

329

2234

1.88

14.92

4.5

3.4

6.89

7.51

mmol/l

1.65

295

1905

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

173

3.36

14.54

2.1

1.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

111

513

2.38

14.23

2.0

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

4.28

14.09

1.1

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

540

4345

2.01

14.04

6.8

3.4

59.37

46.12

u/l

3.80

507

4120

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

692

6221

5.20

14.01

58.0

15.6

19.15

22.61

mg/l

3.61

669

5094

(3012516) Albumin [Mass/volume] in Urine

306

2068

1.84

13.77

4.0

3.4

37.31

52.65

mg/l

1.11

197

1317

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

4.47

13.72

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

109

511

2.34

13.50

1.3

1.2

77.96

145.10

u/ml

1.81

216

(3016650) Hepatitis A virus Ab [Presence] in Serum

121

3.72

13.44

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

5.47

13.33

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

666

5893

3.06

12.87

10.3

5.6

2.02

1.90

mu/l

0.40

642

5502

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

4.07

12.86

1.1

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

9.92

12.81

2.1

1.3

1.50

1.86

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

101

469

2.34

12.76

2.5

2.4

14.02

23.46

au/ml

—

(3020682) Albumin/Creatinine [Ratio] in Urine

306

2107

1.79

12.65

5.0

4.1

8.55

9.62

mg/mmol

0.14

181

1290

(3019550) Sodium [Moles/volume] in Serum or Plasma

695

6322

5.41

12.64

58.8

18.1

139.31

139.71

mmol/l

3.56

689

6213

(3023103) Potassium [Moles/volume] in Serum or Plasma

695

6332

5.34

12.39

59.3

18.2

3.90

3.96

mmol/l

9.72

689

6212

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

507

4071

1.86

12.25

4.2

3.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

108

527

2.24

12.12

3.7

2.5

55.89

67.77

ml/min/173m2

2.58

220

(3044290) Cell count panel - Cerebral spinal fluid

141

3.34

11.97

1.3

—

(3045424) Erythrocytes [Presence] in Urine

319

2.55

11.94

2.7

2.1

0.00

2.28

estimate

0.50

110

(3039162) Centromere protein B Ab [Units/volume] in Serum

3.87

11.42

1.7

1.2

28.22

84.24

u/ml

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

223

2.79

11.39

4.4

4.3

100.68

90.93

2.09

215

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.74

11.19

1.1

1.2

1.45

2.42

u/ml

0.50

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

422

2.30

11.07

1.4

1.3

66.53

36.11

au/ml

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

4.93

11.02

1.5

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

4.84

10.78

1.5

1.2

—

(3019150) Specific gravity of Urine by Refractometry

232

1530

1.77

10.72

8.4

3.9

1.02

kg/l

1.15

166

1008

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

152

3.09

10.61

1.5

1.3

48.25

10.06

e6/l

0.84

109

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

3.91

10.58

1.9

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

169

2.97

10.54

1.5

1.2

43.14

43.63

u/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

4.18

10.50

4.7

4.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

154

3.05

10.38

1.6

1.3

180.97

154.03

e6/l

0.06

115

(3010375) cycloSPORINE [Mass/volume] in Blood

8.29

9.88

28.9

29.9

132.76

111.67

ug/l

0.51

(3044242) Glucose [Moles/volume] in Arterial blood

5.25

9.88

2.0

3.6

7.02

8.07

mmol/l

0.58

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

222

2.65

9.87

1.4

1.2

28.17

2.70

u/ml

—

(3013727) Leukocytes other/Leukocytes in Blood

10.83

9.82

3.7

4.1

42.25

52.06

0.64

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

207

2.69

9.62

1.5

1.2

3.74

2.61

u/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.70

9.59

1.4

1.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

662

5987

2.53

9.49

45.0

14.7

80.16

82.13

ml/min/173m2

1.53

648

5535

(3045414) Leukocytes [Presence] in Urine

114

623

1.99

9.42

3.0

2.1

0.00

0.04

estimate

0.78

133

(3006653) Thiamine [Moles/volume] in Blood

7.06

9.37

1.1

1.5

141.38

160.08

nmol/l

0.62

(40761511) CBC panel - Blood by Automated count

692

6412

3.96

9.32

48.3

13.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

10.85

9.32

1.1

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

110

3.29

9.29

1.1

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

9.20

9.07

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

15.83

9.06

1.3

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

208

2.62

9.01

1.5

1.2

1.62

5.10

u/ml

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.81

8.96

2.0

1.6

—

(3017704) Immunofixation for Urine

6.95

8.89

2.3

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

719

0.28

8.77

1.9

2.0

3.38

3.47

ratio

0.19

586

(3020911) Cortisol [Moles/time] in 24 hour Urine

8.36

8.61

1.8

1.9

166.19

66.59

nmol/24h

0.50

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

166

2.76

8.54

1.3

1.1

0.69

2.04

u/ml

1.16

(3003327) Ova and parasites identified in Stool by Light microscopy

265

2.38

8.45

1.9

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.83

8.40

1.4

1.2

—

(40758558) Short blood count panel - Blood

278

2026

1.61

8.36

12.1

6.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

102

3.24

8.32

1.7

—

(3013637) Mi-2 Ab [Presence] in Serum

7.66

8.20

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

7.66

8.20

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

7.66

8.20

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

7.66

8.20

1.3

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

6.40

8.06

1.1

1.2

1.02

1.07

ratio

1.24

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

647

5872

2.13

7.89

9.7

6.3

40.91

39.09

mmol/mol

5.59

628

5555

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

3.28

7.74

1.0

1.1

—

(4195642) Thrombophilia screening test

3.43

7.73

1.1

1.2

—

(44813793) Dust mix specific IgE antibody measurement

4.17

7.58

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

8.99

7.57

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

233

2.38

7.55

2.6

2.3

0.48

0.78

g/l

0.29

208

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

3.82

7.40

2.5

2.3

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

+∞

7.30

1.9

0.0

208.29

—

nmol/l

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

7.41

7.22

1.8

1.9

14.06

15.96

pmol/l

0.71

(3023430) Cat dander IgE Ab [Units/volume] in Serum

106

3.01

7.20

1.2

1.1

5.45

4.04

u/ml

0.11

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

3.62

7.19

1.1

1.2

—

(3036489) Thrombin time

252

2.28

7.14

4.3

2.8

20.53

21.32

0.70

232

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

375

2.05

7.12

2.8

1.7

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

12.18

7.10

1.8

1.7

1.36

1.26

umol/l

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

171

2.55

7.05

1.6

1.2

2.89

1.10

u/ml

—

(40768441) Liver Pathology biopsy report

3.93

7.02

1.8

1.4

—

(3044941) Cell count panel - Synovial fluid

114

2.89

6.93

2.1

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

199

2.40

6.81

2.2

2.0

4.28

4.86

iu/l

0.15

(3002079) Sodium [Moles/time] in 24 hour Urine

6.19

6.80

1.2

1.5

161.88

164.74

mmol/24h

0.04

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

3.96

6.74

1.2

1.1

276.54

213.80

mg/l

0.43

(3016018) Differential panel - Cerebral spinal fluid

3.37

6.74

1.3

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

178

1220

1.61

6.64

7.7

4.0

88.94

401.52

ng/l

3.00

134

907

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

158

2.55

6.63

1.3

1.7

—

(3042733) HLA Ab [Presence] in Serum

8.80

6.57

4.5

3.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

8.80

6.57

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.99

6.47

1.3

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

136

2.65

6.46

1.2

1.1

0.51

0.76

u/ml

0.28

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

3.36

6.46

2.2

2.4

—

29.73

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

4.12

6.38

1.7

1.1

1.35

0.52

ratio

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

18.20

6.27

2.1

1.8

2.69

3.10

mg/l

—

(21494755) Public health laboratory ask at order entry panel

619

0.35

6.23

1.3

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

3.73

6.23

1.3

1.1

77.40

38.28

mg/l

0.53

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

12.65

6.09

1.5

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

165

2.44

6.07

2.1

1.5

5791.90

13036.51

e6/l

0.99

120

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

105

643

1.74

5.98

3.5

4.3

10.30

26.01

ug/l

0.57

528

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.74

5.95

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

113

2.73

5.90

1.2

1.0

1.39

3.84

u/ml

0.66

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

206

2.26

5.88

1.6

2.2

0.00

0.02

g/l

0.50

190

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

648

5990

1.92

5.88

7.0

5.1

5.75

5.91

mmol/l

2.59

624

5575

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

468

5281

0.67

5.85

61.0

20.2

329.51

331.88

g/l

6.10

462

5259

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

477

1.84

5.84

2.9

2.4

6.30

7.72

ug/l

0.29

428

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.40

5.76

1.2

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

127

2.59

5.69

1.6

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

127

2.59

5.69

1.6

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

4.81

5.64

1.1

1629.82

1571.14

miu/ml

0.09

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

3.60

5.63

2.4

1.5

33.20

25.33

u/ml

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

534

0.34

5.63

1.7

3.92

3.52

mmol/l

—

394

(3033658) Prothrombin time (PT) actual/Normal

223

1660

1.50

5.63

7.4

4.2

93.75

92.08

0.39

212

1622

(3018851) Theophylline [Moles/volume] in Serum or Plasma

13.00

5.59

2.2

1.6

43.67

42.57

umol/l

—

(40768804) Tissue Pathology biopsy report

325

2609

1.45

5.57

2.7

2.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

178

1268

1.54

5.51

1.9

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

3.08

5.41

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

149

2.42

5.40

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

101

2.74

5.39

1.1

1.2

2.50

5.92

u/ml

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

3.24

5.35

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

3.24

5.35

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

3.24

5.35

1.5

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

307

1.97

5.24

2.7

2.4

—

(3022313) Gas panel - Capillary blood

339

1.91

5.10

13.6

5.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

10.11

5.03

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

11.54

4.79

3.1

2.6

1.96

5.14

nmol/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.28

4.78

1.2

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

5.28

4.78

1.0

1.1

127.40

54.83

ng/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

108

2.56

4.76

1.1

—

0.96

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

3.00

4.75

1.3

1.2

71.60

91.72

u/l

0.21

(3044640) Blood type and Crossmatch panel - Blood

266

2105

1.42

4.72

4.2

2.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

7.23

4.66

1.1

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

8.27

4.57

4.6

2.1

1.89

2.64

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

195

2.11

4.53

1.6

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

3.32

4.49

2.3

1.9

1.63

2.13

u/field

—

(3008536) Aspergillus sp Ab [Presence] in Serum

6.74

4.48

1.6

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

143

2.30

4.47

1.1

1.0

0.24

6.19

u/ml

3.41

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.98

4.47

3.6

4.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

2.61

4.42

2.5

3.6

0.82

0.88

nmol/l

0.17

(3026361) Erythrocytes [#/volume] in Blood

701

6766

3.56

4.39

75.5

23.8

4.35

4.48

e12/l

9.23

696

6636

(3010813) Leukocytes [#/volume] in Blood

701

6766

3.56

4.39

75.6

23.9

8.02

6.66

e9/l

42.18

695

6635

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

191

2.10

4.38

1.4

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

3.00

4.31

1.2

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

11.76

4.28

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.91

4.21

3.3

3.0

1.70

1.33

0.19

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

201

2.05

4.21

1.4

2.2

0.00

g/l

-0.00

179

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

3.46

4.20

1.5

1.0

1.14

u/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

109

2.44

4.19

1.2

1.1

10.15

133.36

iu/ml

0.91

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

762

0.52

4.13

6.4

4.9

31.50

32.40

0.25

508

(3014765) Yersinia sp identified in Stool by Organism specific culture

196

2.05

4.10

1.6

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

8.08

4.07

1.3

1.7

—

(3024928) Oxygen saturation in Venous blood

170

2.11

4.03

29.8

4.9

67.38

61.42

0.92

165

(1761482) Bacteria [#/volume] in Urine by Culture

150

2.19

4.02

7.3

4.2

—

(3041354) Potassium [Moles/volume] in Venous blood

2.71

4.02

4.4

2.5

4.01

mmol/l

0.00

(3033705) Calcium.ionized [Moles/volume] in Venous blood

2.71

4.02

4.5

2.5

1.21

1.19

mmol/l

0.30

(3035285) Chloride [Moles/volume] in Venous blood

2.71

4.02

4.5

2.5

105.45

105.47

mmol/l

0.01

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

10.08

4.01

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

205

2.01

4.00

3.3

2.1

2786.17

5036.82

u/l

0.32

(42529406) Shigella sp [Presence] in Stool by Culture

199

2.02

3.95

1.6

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

2.55

3.91

1.1

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

107

2.39

3.87

2.0

1.5

—

(3000492) Spirometry study

668

1.56

3.85

1.6

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

240

1920

1.38

3.83

5.4

2.9

0.00

0.06

—

(3016330) Potassium [Moles/time] in 24 hour Urine

8.82

3.78

1.1

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

8.82

3.78

3.3

2.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

12.09

3.77

4.3

4.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.81

3.56

1.1

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

172

2.03

3.54

3.0

1.8

60.79

41.82

nmol/l

0.88

166

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.28

3.51

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.28

3.51

5.8

2.2

0.61

0.62

mmol/l

0.08

(3052851) Hemolysis interference index of Serum or Plasma

173

2.01

3.49

4.3

2.7

1.43

2.12

index

0.37

(3008401) Mugwort IgE Ab [Units/volume] in Serum

139

2.13

3.48

1.1

0.16

1.62

u/ml

1.09

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.56

3.41

1.2

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

4.12

3.40

1.4

1.1

0.89

33.84

u/ml

—

(3037121) Protein [Mass/volume] in Urine

218

1.88

3.39

6.4

4.4

300.55

339.92

mg/l

0.16

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

8.63

3.27

1.5

3.6

—

(3024869) Neuronal Ab [Presence] in Serum

8.63

3.27

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.78

3.24

3.4

5.07

4.55

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.78

3.24

3.4

11.18

10.68

kpa

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

4.21

3.20

1.7

1.3

9.45

8.25

ug/l

—

(3005570) Glucose [Moles/volume] in Urine

2.76

3.17

2.0

2.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

2.44

3.16

3.1

2.4

0.32

1.27

g/24h

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.57

3.14

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

228

0.34

3.10

1.0

1.1

—

0.71

—

(3023511) Choriogonadotropin [Units/volume] in Urine

112

2.18

3.09

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

7.55

3.06

1.8

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.88

3.02

1.1

1.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.78

3.00

2.6

3.1

489.86

1128.27

1.39

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.78

3.00

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

10.06

2.98

1.0

7.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

281

1.72

2.97

16.6

6.3

25.70

24.94

mmol/l

1.26

272

(3008898) HLA-B27 [Presence]

282

1.71

2.94

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

147

1130

1.38

2.92

4.6

3.0

3.02

0.99

e6/l

0.43

588

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.13

2.89

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.13

2.89

1.7

1.9

—

(3020650) Glucose [Presence] in Urine

4.13

2.89

2.1

1.2

0.00

estimate

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

292

1.69

2.86

1.4

1.5

0.35

0.33

mg/l

0.03

128

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.95

2.78

1.7

1.9

—

(1761868) Lipid panel - Serum or Plasma

302

2599

1.28

2.68

4.1

3.1

—

(3045142) Bone marrow Pathology biopsy report

2.36

2.67

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.49

2.63

1.1

1.2

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

3.63

2.58

5.9

3.4

196.56

196.24

u/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

620

5881

1.42

2.56

5.3

4.3

1.54

1.28

mmol/l

10.16

584

5466

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

217

1.74

2.53

4.0

1.9

—

(40768446) Kidney Pathology biopsy report

3.49

2.49

3.3

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.41

2.47

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.41

2.47

1.1

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

134

1043

1.35

2.45

5.1

3.1

4.30

2.45

e6/l

0.84

504

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.92

2.42

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.03

2.40

1.0

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.37

2.40

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

104

2.05

2.38

1.4

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

2.44

2.38

1.9

1.3

17532.57

160394.72

e6/l

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.06

2.36

1.6

2.2

44.00

114.24

umol/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

105

2.03

2.33

1.2

1.1

—

1.65

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.24

2.31

1.2

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.25

2.29

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

317

2783

1.25

2.28

2.3

1.9

1.65

1.35

mmol/l

5.29

258

2375

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.92

2.25

1.0

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.13

2.23

1.3

—

(4268621) Lupus anticoagulant assay

2.22

2.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

240

0.41

2.20

1.3

1.1

1.58

1.60

g/l

—

240

(3003434) Protein [Mass/volume] in Pleural fluid

2.27

2.19

1.7

1.5

22.74

32.74

g/l

1.71

(21494890) Protein electrophoresis panel - 24 hour Urine

2.27

2.19

4.9

2.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.31

2.15

1.0

1.1

0.05

0.02

u/ml

—

(3024263) Appearance of Synovial fluid

3.03

2.15

2.4

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.64

2.15

1.0

—

(3028433) Virus identified in Specimen by Culture

3.22

2.10

1.0

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

146

1.81

2.09

3.3

2.5

67.74

142.87

ug/min

0.69

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.93

2.08

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.93

2.08

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.93

2.08

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.93

2.08

1.7

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.73

2.07

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

5.03

2.07

1.4

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.03

2.07

1.0

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.02

2.04

1.0

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

385

0.56

1.99

1.5

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

258

1.58

1.97

2.9

3.1

15.20

1167.66

u/ml

1.38

224

(4034850) Laboratory test

195

1.67

1.96

29.6

9.4

—

(4024509) Urine culture

283

1.55

1.94

2.1

2.0

—

(3024471) HLA-A [Type]

3.77

1.94

1.0

—

(3024932) HLA-DR beta [Type]

3.77

1.94

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.78

1.79

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

647

6248

1.39

1.78

7.0

5.8

2.59

2.76

mmol/l

5.04

613

5859

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

641

1.35

1.77

3.2

2.5

28.74

37.01

u/l

1.71

539

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

138

0.36

1.76

1.4

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

639

6163

1.36

1.73

6.4

5.2

4.63

4.72

mmol/l

1.29

605

5800

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.15

1.72

1.1

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

3.86

1.71

1.8

1.9

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

3.86

1.71

5.0

1.0

135.60

110.92

—

(3004616) Nuclear Ab [Presence] in Serum

1.97

1.70

1.3

—

(3002256) Pathology report gross observation

110

878

1.30

1.70

1.5

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

188

1.62

1.68

1.4

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

204

1.60

1.68

4.0

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

221

1.57

1.65

1.3

182.90

234.12

miu/ml

—

103

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

221

1.57

1.65

1.6

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.59

1.62

1.0

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

574

1.34

1.57

2.1

1.7

—

(3023410) Appearance of Cerebral spinal fluid

1.94

1.55

1.5

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.35

1.52

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.92

1.50

1.1

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.45

1.48

1.1

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.45

1.48

1.1

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

635

6143

1.32

1.47

6.3

5.1

1.51

1.50

mmol/l

0.38

602

5751

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.24

1.47

2.1

1.9

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.39

1.46

1.0

1.1

131.22

200.76

iu/ml

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.32

1.43

1.2

1.8

0.56

2.32

u/field

—

(3018333) Ribosomal P Ab [Presence] in Serum

2.02

1.38

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

162

0.49

1.37

1.5

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

2.21

1.37

1.2

1.8

10.38

11.96

umol/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1.77

1.36

1.1

1.0

0.05

0.27

u/ml

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.51

1.30

2.7

2.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

167

1444

1.20

1.29

6.0

5.4

9.83

2.42

ug/l

0.50

150

1307

(40768795) Lymph node Pathology biopsy report

1.95

1.28

1.3

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

747

1.27

1.28

1.6

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.02

1.28

1.3

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.30

1.27

1.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

115

1.67

1.26

4.4

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

118

0.42

1.25

1.8

1.6

—

(4198724) Urine methamphetamine measurement

2.41

1.24

1.0

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

2.06

1.22

1.3

1.2

0.38

2.67

u/ml

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.18

1.21

1.3

1.1

—

(3003694) ABO and Rh group [Type] in Blood

209

1862

1.17

1.15

1.8

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

259

1.41

1.14

1.7

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.35

1.12

2.4

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.01

1.12

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.72

1.12

2.0

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.39

1.09

2.2

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.39

1.09

3.0

3.3

2.60

5.14

ug/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

229

1.42

1.05

1.4

1.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.28

1.03

1.2

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

639

1.25

1.03

2.4

1.9

—

(3045788) Cell count panel - Pleural fluid

1.89

1.00

1.6

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

247

0.64

0.97

2.7

1.1

0.88

0.91

g/l

0.32

247

(3051651) Icteric interference index of Serum or Plasma

1.95

0.97

4.7

2.7

0.86

0.83

index

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

174

1.45

0.96

1.4

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

482

1.27

0.95

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.66

0.95

1.9

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.62

0.88

2.1

1.4

—

(3049717) Cytology report of Urine Cyto stain

221

1.37

0.87

1.8

2.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

709

1.21

0.86

18.3

6.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

137

1.47

0.85

1.5

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

137

1.47

0.85

1.5

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.60

0.85

2.1

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.75

0.82

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

761

1.19

0.81

1.8

1.7

1.49

1.45

0.31

669

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.82

0.79

2.0

1.0

—

(3025577) Chromium [Mass/volume] in Blood

1.82

0.79

2.0

2.3

2.08

2.24

ug/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

351

1.27

0.76

1.5

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

702

1.19

0.74

2.4

2.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.09

0.74

1.0

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

2.01

0.73

1.2

5.66

6.89

mmol/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.56

0.72

2.0

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.56

0.72

2.0

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.56

0.72

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.52

0.70

1.5

1.4

—

(44806420) Estimation of glomerular filtration rate

1.57

0.69

3.0

2.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.60

0.68

1.4

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

880

0.85

0.68

3.7

3.2

1.02

0.79

ug/l

0.24

559

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

271

1.27

0.62

1.4

1.6

24.00

10.66

u/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.67

0.61

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.58

0.0

1.0

—

39.32

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

331

1.22

0.54

1.9

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.58

0.54

1.2

1.3

20.00

17.63

u/l

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.50

0.51

1.2

1.3

95.00

98.43

u/l

—

(3011288) Drugs identified in Urine by Screen method Nominal

171

1.30

0.50

6.3

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.41

0.42

1.1

1.0

—

(40768806) Pleura Pathology biopsy report

1.38

0.41

1.9

1.8

—

(3033799) Differential panel - Peritoneal fluid

0.00

0.40

0.0

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.47

0.40

1.2

7.1

—

35.63

u/ml

—

(3047189) Immunofixation for 24 hour Urine

1.43

0.39

5.2

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

169

1591

1.08

0.37

4.3

2.4

—

(3044927) Protein electrophoresis panel - Urine

1.29

0.36

1.3

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.28

0.32

2.3

1.4

62.33

73.19

umol/l

—

(3051611) Lipemic interference index of Serum or Plasma

1.32

0.31

4.7

2.7

22.86

12.50

index

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

100

0.70

0.30

3.4

1.7

—

(40768800) Prostate Pathology biopsy report

1.31

0.30

1.1

—

(3012441) Differential panel - Pleural fluid

1.25

0.29

1.6

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

246

0.85

0.26

1.6

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

397

1.12

0.25

2.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.74

0.24

1.3

1.5

75.11

51.58

ug/l

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.25

0.22

1.4

1.6

78.20

110.48

ng/l

—

(3022621) pH of Urine by Test strip

517

1.09

0.22

5.6

2.2

6.18

6.10

0.33

347

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

192

1.15

0.21

4.4

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

9.90

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.8

—

3.08

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

743

0.94

0.18

1.9

1.5

—

(3016879) Cocaine [Presence] in Urine

235

1.11

0.16

3.8

1.4

—

(40768793) Breast Pathology biopsy report

197

1.12

0.15

1.4

1.3

—

(1002224) Polysomnography panel

362

0.94

0.10

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.15

0.09

1.4

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1.06

0.09

1.0

1.5

—

1.01

—

(21494434) Karyotype in Bone marrow

1.05

0.08

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

569

1.04

0.08

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

254

1.07

0.08

3.7

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

122

1200

1.02

0.05

1.7

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

110

1.09

0.05

1.1

—

(3025130) Human papilloma virus identified in Specimen

109

0.92

0.04

1.1

1.7

—

(3019225) pH of Specimen

573

0.98

0.04

6.9

4.1

7.38

7.35

0.48

408

(4094501) Cardiovascular stress test using bicycle ergometer

179

0.95

0.03

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

390

1.03

0.03

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

251

1.04

0.02

3.8

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

119

1178

1.01

0.02

4.9

4.6

19.18

21.74

0.97

571

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

168

0.95

0.02

2.9

1.8

—

(3027944) Amphetamines [Presence] in Urine

254

1.02

0.00

3.9

1.5

—

(3028300) Cannabinoids [Presence] in Urine

254

1.02

0.00

3.9

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

83.33

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

-0.00

0.0

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

65.67

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

65.88

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

-0.00

0.0

5.0

—

8.17

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

2.5

—

37.00

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.2

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

-0.00

0.0

3.9

—

0.17

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY and mortality.

Females

Parameter	HR [95% CI]	p-value
DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY	3.3 [2.56, 4.25]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.61

During the follow-up period (1.1.1998 — 31.12.2019), 228 out of 1280 females with DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY died.

Males

Parameter	HR [95% CI]	p-value
DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY	3.434 [2.34, 5.04]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 146 out of 676 males with DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY died.

Mortality risk

Mortality risk for people of age

years, who have DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY.

N-year risk	Females	Males
1	0.391%	0.637%
5	2.02%	4.028%
10	5.264%	9.927%
15	9.781%	17.921%
20	17.281%	28.456%

Relationships between endpoints

↥

Index endpoint: DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY – Drug-induced adrenocortical insufficiency

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Drug-induced adrenocortical insufficiency

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints